BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 010340
(512 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 119 bits (298), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 90/294 (30%), Positives = 140/294 (47%), Gaps = 30/294 (10%)
Query: 57 FSLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPK- 115
FSL +L+ A++NFS+ I+ G VYKGRL DG +AVK+ + +
Sbjct: 28 FSLRELQVASDNFSNKNILGRGG---FGKVYKGRLADGT----LVAVKRLKEERXQGGEL 80
Query: 116 QFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW-ENQT-IEWAM 173
QF E + H+ L L G+C ERLLV YM N ++A L E+Q ++W
Sbjct: 81 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 174 RLRVALYIAEALDYCSSEGRP--LYHDLNAYRVLFDENGDPRLSCFGLMK-----NSRDG 226
R R+AL A L Y P ++ D+ A +L DE + + FGL K +
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 227 KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHI---------PPSHALDMI 277
+ + + PEYL G+ + ++ +F +G +LL+L++G+ LD +
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 278 RG----KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+G K + L+D L+GN+ EE + +A C Q P ERP ++V L
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 117 bits (292), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 89/294 (30%), Positives = 139/294 (47%), Gaps = 30/294 (10%)
Query: 57 FSLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPK- 115
FSL +L+ A++NF + I+ G VYKGRL DG +AVK+ + +
Sbjct: 20 FSLRELQVASDNFXNKNILGRGG---FGKVYKGRLADGX----LVAVKRLKEERTQGGEL 72
Query: 116 QFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW-ENQT-IEWAM 173
QF E + H+ L L G+C ERLLV YM N ++A L E+Q ++W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 174 RLRVALYIAEALDYCSSEGRP--LYHDLNAYRVLFDENGDPRLSCFGLMK-----NSRDG 226
R R+AL A L Y P ++ D+ A +L DE + + FGL K +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 227 KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHI---------PPSHALDMI 277
+ + + PEYL G+ + ++ +F +G +LL+L++G+ LD +
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 278 RG----KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+G K + L+D L+GN+ EE + +A C Q P ERP ++V L
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 112 bits (280), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 139/289 (48%), Gaps = 29/289 (10%)
Query: 59 LADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFA 118
L DL ATNNF F++ G VYKG L+DG +A+K+ T + ++F
Sbjct: 31 LVDLEEATNNFDHKFLI---GHGVFGKVYKGVLRDGAK----VALKRRTPESSQGIEEFE 83
Query: 119 DEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE--NQTIEWAMRLR 176
E + RH L +LIG+C + +E +L+ +YM N L +HL+ + ++ W RL
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 177 VALYIAEALDYCSSEGRPLYH-DLNAYRVLFDENGDPRLSCFGLMKNSRD-GKSY----- 229
+ + A L Y + R + H D+ + +L DEN P+++ FG+ K + G+++
Sbjct: 144 ICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 230 STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKH-IPPSHALDMI----------R 278
L Y PEY GR+T +S ++SFG VL ++L + I S +M+
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 279 GKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++D +L E D A +CL +RP+ D++ L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 83/289 (28%), Positives = 135/289 (46%), Gaps = 29/289 (10%)
Query: 59 LADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFA 118
L DL ATNNF F++ G VYKG L+DG +A+K+ T + ++F
Sbjct: 31 LVDLEEATNNFDHKFLI---GHGVFGKVYKGVLRDGAK----VALKRRTPESSQGIEEFE 83
Query: 119 DEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE--NQTIEWAMRLR 176
E + RH L +LIG+C + +E +L+ +YM N L +HL+ + ++ W RL
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 177 VALYIAEALDYCSSEGRPLYH-DLNAYRVLFDENGDPRLSCFGLMKNSRD------GKSY 229
+ + A L Y + R + H D+ + +L DEN P+++ FG+ K +
Sbjct: 144 ICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 230 STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKH-IPPSHALDMI----------R 278
L Y PEY GR+T +S ++SFG VL ++L + I S +M+
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 279 GKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++D +L E D A +CL +RP+ D++ L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 106 bits (265), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 89/302 (29%), Positives = 141/302 (46%), Gaps = 34/302 (11%)
Query: 54 FAEFSLADLRAATNNFSSDFIV---SESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHA 110
F FS +L+ TNNF I ++ GE VVYKG + N +AVKK A
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA--A 64
Query: 111 WPD------PKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW 164
D +QF E + K +H+ L L+G+ DGD+ LV YMPN +L L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 165 ENQ-TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS 223
+ + W MR ++A A +++ E ++ D+ + +L DE ++S FGL + S
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 224 RD------GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG-----KHIPPSH 272
AY PE LR G +TP+S I+SFG VLL++++G +H P
Sbjct: 184 EKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 273 ALDMIRGKNILHLMDS-HLEGNFSSEEATVV---FDLASRCLQYEPRERPNTKDLVSTLA 328
LD+ +++ + ++T V + +AS+CL + +RP+ K + L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 329 PL 330
+
Sbjct: 303 EM 304
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 89/302 (29%), Positives = 141/302 (46%), Gaps = 34/302 (11%)
Query: 54 FAEFSLADLRAATNNFSSDFIV---SESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHA 110
F FS +L+ TNNF I ++ GE VVYKG + N +AVKK A
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA--A 64
Query: 111 WPD------PKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW 164
D +QF E + K +H+ L L+G+ DGD+ LV YMPN +L L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 165 ENQ-TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS 223
+ + W MR ++A A +++ E ++ D+ + +L DE ++S FGL + S
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 224 RD------GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG-----KHIPPSH 272
AY PE LR G +TP+S I+SFG VLL++++G +H P
Sbjct: 184 EKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 273 ALDMIRGKNILHLMDS-HLEGNFSSEEATVV---FDLASRCLQYEPRERPNTKDLVSTLA 328
LD+ +++ + ++T V + +AS+CL + +RP+ K + L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 329 PL 330
+
Sbjct: 303 EM 304
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 89/302 (29%), Positives = 141/302 (46%), Gaps = 34/302 (11%)
Query: 54 FAEFSLADLRAATNNFSSDFIV---SESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHA 110
F FS +L+ TNNF I ++ GE VVYKG + N +AVKK A
Sbjct: 6 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA--A 58
Query: 111 WPD------PKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW 164
D +QF E + K +H+ L L+G+ DGD+ LV YMPN +L L
Sbjct: 59 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 165 ENQ-TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS 223
+ + W MR ++A A +++ E ++ D+ + +L DE ++S FGL + S
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARAS 177
Query: 224 RD------GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG-----KHIPPSH 272
AY PE LR G +TP+S I+SFG VLL++++G +H P
Sbjct: 178 EKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 236
Query: 273 ALDMIRGKNILHLMDS-HLEGNFSSEEATVV---FDLASRCLQYEPRERPNTKDLVSTLA 328
LD+ +++ + ++T V + +AS+CL + +RP+ K + L
Sbjct: 237 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296
Query: 329 PL 330
+
Sbjct: 297 EM 298
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 100 bits (248), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 88/304 (28%), Positives = 141/304 (46%), Gaps = 44/304 (14%)
Query: 54 FAEFSLADLRAATNNFSSDFIV---SESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHA 110
F FS +L+ TNNF I ++ GE VVYKG + N +AVKK A
Sbjct: 3 FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-----NNTTVAVKKLA--A 55
Query: 111 WPD------PKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW 164
D +QF E K +H+ L L+G+ DGD+ LV Y PN +L L
Sbjct: 56 MVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 165 ENQ-TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS 223
+ + W R ++A A +++ E ++ D+ + +L DE ++S FGL + S
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFL-HENHHIHRDIKSANILLDEAFTAKISDFGLARAS 174
Query: 224 RD------GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMI 277
AY PE LR G +TP+S I+SFG VLL++++G +P A+D
Sbjct: 175 EKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG--LP---AVDEH 228
Query: 278 RGKNIL-----------HLMDSHLEGNFSSEEATVV---FDLASRCLQYEPRERPNTKDL 323
R +L ++ +++ + ++T V + +AS+CL + +RP+ K +
Sbjct: 229 REPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKV 288
Query: 324 VSTL 327
L
Sbjct: 289 QQLL 292
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 22/262 (8%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 13 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 68 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 125
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTP 248
L+ DL A L ++ G ++S FGL + D + S+ + ++PPE L + +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFDL 305
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+ +
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYTI 238
Query: 306 ASRCLQYEPRERPNTKDLVSTL 327
C + ERP K L+S +
Sbjct: 239 MYSCWHEKADERPTFKILLSNI 260
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 22/262 (8%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 140
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTP 248
L+ DL A L ++ G ++S FGL + D + S+ + ++PPE L + +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFDL 305
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+ +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYTI 253
Query: 306 ASRCLQYEPRERPNTKDLVSTL 327
C + ERP K L+S +
Sbjct: 254 MYSCWHEKADERPTFKILLSNI 275
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 120
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA------YTPPEYLRNGRVT 247
L+ DL A L ++ G ++S FGL + D + Y++++ ++PPE L + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 248 PESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFD 304
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYT 232
Query: 305 LASRCLQYEPRERPNTKDLVSTL 327
+ C + ERP K L+S +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNI 255
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 140
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA------YTPPEYLRNGRVT 247
L+ DL A L ++ G ++S FGL + D + Y++++ ++PPE L + +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 248 PESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFD 304
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYT 252
Query: 305 LASRCLQYEPRERPNTKDLVSTL 327
+ C + ERP K L+S +
Sbjct: 253 IMYSCWHEKADERPTFKILLSNI 275
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 12 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 66
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 67 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 124
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA------YTPPEYLRNGRVT 247
L+ DL A L ++ G ++S FGL + D + Y++++ ++PPE L + +
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 248 PESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFD 304
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYT 236
Query: 305 LASRCLQYEPRERPNTKDLVSTL 327
+ C + ERP K L+S +
Sbjct: 237 IMYSCWHEKADERPTFKILLSNI 259
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 19 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 73
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 74 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 131
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA------YTPPEYLRNGRVT 247
L+ DL A L ++ G ++S FGL + D + Y++++ ++PPE L + +
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 248 PESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFD 304
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYT 243
Query: 305 LASRCLQYEPRERPNTKDLVSTL 327
+ C + ERP K L+S +
Sbjct: 244 IMYSCWHEKADERPTFKILLSNI 266
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
+ E G VV G+ + D +A+K K +F +EA + L H++L
Sbjct: 13 FLKELGTGQFGVVKYGKWRGQYD----VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
L G C ++ EYM N L +L ++ + L + + EA++Y S+ +
Sbjct: 68 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK-Q 125
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA------YTPPEYLRNGRVT 247
L+ DL A L ++ G ++S FGL + D + Y++++ ++PPE L + +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 248 PESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI---LHLMDSHLEGNFSSEEATVVFD 304
+S I++FG ++ ++ S +P + ++I L L HL +SE+ V+
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL----ASEK---VYT 237
Query: 305 LASRCLQYEPRERPNTKDLVSTL 327
+ C + ERP K L+S +
Sbjct: 238 IMYSCWHEKADERPTFKILLSNI 260
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 35 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIXIVTEYMSKGSLLD 91
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 92 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 150
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 151 ARLIEDNEXTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 208
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 209 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 259
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 38 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 94
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 95 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 153
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 154 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 211
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 212 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 262
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 294 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 350
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 409
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 410 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 468 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 19/261 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ--FADEAWGVGKLRHKRLANLIGYCCDGD 143
VYKG L+ + + K K + + ++ F EA +G+ H + L G
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 144 ERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALY--IAEALDYCSSEGRPLYHDLNA 201
+++ EYM N L K L + E+++ V + IA + Y ++ ++ DL A
Sbjct: 120 PMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY-VHRDLAA 175
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LAYTPPEYLRNGRVTPESVIFS 254
+L + N ++S FGL + D +Y+T+ + +T PE + + T S ++S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235
Query: 255 FGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEP 314
FG V+ ++++ P + ++ ++ + + ++ L +C Q E
Sbjct: 236 FGIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 291
Query: 315 RERPNTKDLVSTLAPLQNRPD 335
RP D+VS L L PD
Sbjct: 292 ARRPKFADIVSILDKLIRAPD 312
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 81 KAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIG 137
K + KG D G+ +AVK A + F EA + +LRH L L+G
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 138 YCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLY 196
+ L +V EYM +L +L + L+ +L + EA++Y EG
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV 139
Query: 197 H-DLNAYRVLFDENGDPRLSCFGLMKNSRDGK-SYSTNLAYTPPEYLRNGRVTPESVIFS 254
H DL A VL E+ ++S FGL K + + + + +T PE LR + + +S ++S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 199
Query: 255 FGTVLLDLLSGKHIP 269
FG +L ++ S +P
Sbjct: 200 FGILLWEIYSFGRVP 214
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 120
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + S L Y PPE +
Sbjct: 121 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMI 179
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 180 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 232
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVL 256
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVGEYMSKGSLLD 267
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 326
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 327 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 385 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 81 KAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIG 137
K + KG D G+ +AVK A + F EA + +LRH L L+G
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 138 YCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLY 196
+ L +V EYM +L +L + L+ +L + EA++Y EG
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV 124
Query: 197 H-DLNAYRVLFDENGDPRLSCFGLMKNSRDGK-SYSTNLAYTPPEYLRNGRVTPESVIFS 254
H DL A VL E+ ++S FGL K + + + + +T PE LR + + +S ++S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 255 FGTVLLDLLSGKHIP 269
FG +L ++ S +P
Sbjct: 185 FGILLWEIYSFGRVP 199
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 14/245 (5%)
Query: 81 KAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIG 137
K + KG D G+ +AVK A + F EA + +LRH L L+G
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 138 YCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLY 196
+ L +V EYM +L +L + L+ +L + EA++Y EG
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV 311
Query: 197 H-DLNAYRVLFDENGDPRLSCFGLMKNSRDGK-SYSTNLAYTPPEYLRNGRVTPESVIFS 254
H DL A VL E+ ++S FGL K + + + + +T PE LR + + +S ++S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 255 FGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEP 314
FG +L ++ S +P I K+++ ++ + + V+D+ C +
Sbjct: 372 FGILLWEIYSFGRVPYPR----IPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDA 427
Query: 315 RERPN 319
RP
Sbjct: 428 ATRPT 432
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 267
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 326
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 327 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 385 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 62.8 bits (151), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 267
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 326
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 327 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 385 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 81 KAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIG 137
K + KG D G+ +AVK A + F EA + +LRH L L+G
Sbjct: 15 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 138 YCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLY 196
+ L +V EYM +L +L + L+ +L + EA++Y EG
Sbjct: 73 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV 130
Query: 197 H-DLNAYRVLFDENGDPRLSCFGLMKNSRDGK-SYSTNLAYTPPEYLRNGRVTPESVIFS 254
H DL A VL E+ ++S FGL K + + + + +T PE LR + +S ++S
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWS 190
Query: 255 FGTVLLDLLSGKHIP 269
FG +L ++ S +P
Sbjct: 191 FGILLWEIYSFGRVP 205
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 62.4 bits (150), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 42 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMNKGSLLD 98
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + ++ IA + Y ++ DL A +L EN +++ FGL
Sbjct: 99 FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 157
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 158 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 215
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 216 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 266
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 42 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMNKGSLLD 98
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + ++ IA + Y ++ DL A +L EN +++ FGL
Sbjct: 99 FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 157
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 158 ARLIEDNEWTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 215
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + EP ERP + L + L
Sbjct: 216 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 266
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 67 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 121
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 122 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 180
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 181 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 233
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 234 GARDLISRLLKHNPSQRPMLREVL 257
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 68 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 122
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 234
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVCEYMSKGSLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 22/282 (7%)
Query: 70 SSDFIVSES-GEKAPNVVYKGRLQDGND----NRRWIAVKKFTKHAWPDPKQFADEAWGV 124
+ D I +ES G+ ++KG ++ D + + +K K + F + A +
Sbjct: 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 125 GKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEA 184
KL HK L G C GDE +LV E++ +L +L +N I +L VA +A A
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAA 125
Query: 185 LDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--------NLAYT 236
+ + E ++ ++ A +L D + +K S G S + + +
Sbjct: 126 MHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 237 PPEYLRNGR-VTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PPE + N + + + +SFGT L ++ SG P S ALD R D H
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-ALDSQRKLQFYE--DRH---QLP 238
Query: 296 SEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVP 337
+ +A + +L + C+ YEP RP+ + ++ L L VP
Sbjct: 239 APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 36 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 92
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 93 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 151
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 152 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 209
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 210 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 260
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVIEYMSKGSLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEXTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 82 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 136
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 137 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 195
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 196 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 248
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 249 GARDLISRLLKHNPSQRPMLREVL 272
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 35/261 (13%)
Query: 95 NDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPN 154
++ +AVK K F EA + L+H+ + G C DGD ++V EYM +
Sbjct: 42 TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 101
Query: 155 DTLAKHL-FHWENQTI-------------EWAMRLRVALYIAEALDYCSSEGRPLYHDLN 200
L K L H + I + L +A IA + Y +S+ ++ DL
Sbjct: 102 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLA 160
Query: 201 AYRVLFDENGDPRLSCFGLMKNS------RDGKSYSTNLAYTPPEYLRNGRVTPESVIFS 254
L N ++ FG+ ++ R G + + PPE + + T ES ++S
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 255 FGTVLLDLLS-GK----HIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRC 309
FG +L ++ + GK + + ++ I +L +E V+D+ C
Sbjct: 221 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE------RPRVCPKE---VYDVMLGC 271
Query: 310 LQYEPRERPNTKDLVSTLAPL 330
Q EP++R N K++ L L
Sbjct: 272 WQREPQQRLNIKEIYKILHAL 292
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 68 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 122
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 234
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 91 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 145
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 146 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 204
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 205 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 257
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 258 GARDLISRLLKHNPSQRPMLREVL 281
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 120
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 121 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI 179
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 180 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 232
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVL 256
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 68 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 122
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 234
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P + K L Q + R A YI E
Sbjct: 70 LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-----QKLSKFDEQRTATYITELAN 124
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 236
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVL 260
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 68 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 122
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI 181
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 234
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 69 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 123
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 182
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 183 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 235
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 236 GARDLISRLLKHNPSQRPMLREVL 259
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLAAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 70 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 124
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 236
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVL 260
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVIEYMSKGSLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM +L
Sbjct: 34 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 90
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 91 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 149
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 150 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 207
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 208 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 258
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 64 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 118
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 119 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 177
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 178 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 230
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 231 GARDLISRLLKHNPSQRPMLREVL 254
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 70 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 124
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI 183
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR E V ++S G + + L GK PP A + S +E F
Sbjct: 184 -EGRXHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 236
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 237 GARDLISRLLKHNPSQRPXLREVL 260
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 62 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 116
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 117 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 175
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 176 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 228
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 229 GARDLISRLLKHNPSQRPMLREVL 252
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGCLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 119 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 176
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L + ++ + P +D+ + +L D
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE-IATYGMSPYPGIDLSQVYELLE-KDY 234
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 235 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 267
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P + K L Q + R A YI E
Sbjct: 70 LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-----QKLSKFDEQRTATYITELAN 124
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI 183
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 236
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVL 260
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + K+RH++L L Y +E + +V EYM +L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 117
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 118 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 175
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KDY 233
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 234 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 266
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK K + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 46 VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 105 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 163
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 164 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 221
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 222 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 267
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 67 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 121
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 122 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 180
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 181 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 233
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 234 GARDLISRLLKHNPSQRPMLREVL 257
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 119 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 176
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KDY 234
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 235 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 267
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 68 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 122
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 181
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 234
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 43 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 160
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 161 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 218
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 219 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 264
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 70 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 124
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 183
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 236
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVL 260
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 113
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 114 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 171
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L + ++ + P +D+ + +L D
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE-IATYGMSPYPGIDLSQVYELLE-KDY 229
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 230 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 262
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 113
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 114 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 171
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L + ++ + P +D+ + +L D
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE-IATYGMSPYPGIDLSQVYELLE-KDY 229
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 230 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 262
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 18/235 (7%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+A+K K P+ F EA + KLRH++L L Y +E + +V EYM L
Sbjct: 45 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVMEYMSKGCLLD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + + + +A IA + Y ++ DL A +L EN +++ FGL
Sbjct: 102 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
+ +R G + + +T PE GR T +S ++SFG +L +L + +P
Sbjct: 161 ARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ + +L ++ E + DL +C + +P ERP + L + L
Sbjct: 219 MVN----REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 91 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 145
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 146 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMI 204
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 205 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 257
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 258 GARDLISRLLKHNPSQRPMLREVL 281
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 120
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 121 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 179
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 180 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 232
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVL 256
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 41 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 158
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 159 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 216
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 217 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 262
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 119 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 176
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L + ++ + P +D+ + +L D
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE-IATYGMSPYPGIDLSQVYELLE-KDY 234
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 235 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 267
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 41 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 158
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 159 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 216
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 217 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 262
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 43 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 160
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 161 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 218
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 219 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 264
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 41 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 158
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 159 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 216
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 217 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 262
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 68 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 122
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L G+ +++ FG ++ + L Y PPE +
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMI 181
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRI----SRVEFTFPDFVTE 234
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 41 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 158
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 159 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 216
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 217 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 262
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 54 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 112
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 113 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 171
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 172 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 229
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 230 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 275
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 22/282 (7%)
Query: 70 SSDFIVSES-GEKAPNVVYKGRLQDGND----NRRWIAVKKFTKHAWPDPKQFADEAWGV 124
+ D I +ES G+ ++KG ++ D + + +K K + F + A +
Sbjct: 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 125 GKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEA 184
KL HK L G C GDE +LV E++ +L +L +N I +L VA +A A
Sbjct: 67 SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAWA 125
Query: 185 LDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--------NLAYT 236
+ + E ++ ++ A +L D + +K S G S + + +
Sbjct: 126 MHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 237 PPEYLRNGR-VTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PPE + N + + + +SFGT L ++ SG P S ALD R D H
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-ALDSQRKLQFYE--DRH---QLP 238
Query: 296 SEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVP 337
+ +A + +L + C+ YEP RP+ + ++ L L VP
Sbjct: 239 APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 105/249 (42%), Gaps = 32/249 (12%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDT 156
N+ +A+K + A + + F +EA + KL H +L L G C + LV E+M +
Sbjct: 30 NKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 157 LAKHLFHWENQTIEWAMRLRVALYIAEA-----LDYCSS-----EGRPLYHDLNAYRVLF 206
L+ +L R + L+ AE LD C E ++ DL A L
Sbjct: 89 LSDYL------------RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLV 136
Query: 207 DENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLD 261
EN ++S FG+ + D + S+ + + PE R + +S ++SFG ++ +
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 196
Query: 262 LLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTK 321
+ S IP + ++ + + +T V+ + + C + P +RP
Sbjct: 197 VFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 252
Query: 322 DLVSTLAPL 330
L+ LA +
Sbjct: 253 RLLRQLAAI 261
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 114 PKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWA 172
P+ F EA + KLRH++L L Y +E + +V EYM +L L + +
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 281
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK-------NSRD 225
+ +A IA + Y ++ DL A +L EN +++ FGL + +R
Sbjct: 282 QLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ 340
Query: 226 GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHL 285
G + + +T PE GR T +S ++SFG +L +L + +P ++ + +L
Sbjct: 341 GAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQ 394
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++ E + DL +C + +P ERP + L + L
Sbjct: 395 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 436
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 21/272 (7%)
Query: 72 DFIVSES-GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
D ++ E G V+ GRL+ N +AVK + PD K +F EA + + H
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNT---LVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCS 189
+ LIG C +V E + L E + L++ A ++Y
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 190 SEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYTPPEYLRN 243
S+ ++ DL A L E ++S FG+ + DG ++ + +T PE L
Sbjct: 231 SKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 244 GRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT--V 301
GR + ES ++SFG +L + S P + + + ++ G E
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPN----LSNQQTREFVEKG--GRLPCPELCPDA 343
Query: 302 VFDLASRCLQYEPRERPNTKDLVSTLAPLQNR 333
VF L +C YEP +RP+ + L ++ R
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 106/249 (42%), Gaps = 32/249 (12%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDT 156
N+ +A+K + A + + F +EA + KL H +L L G C + LV E+M +
Sbjct: 31 NKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89
Query: 157 LAKHLFHWENQTIEWAMRLRVALYIAEA-----LDYCSS-----EGRPLYHDLNAYRVLF 206
L+ +L R + L+ AE LD C E ++ DL A L
Sbjct: 90 LSDYL------------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137
Query: 207 DENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLD 261
EN ++S FG+ + D + S+ + + PE R + +S ++SFG ++ +
Sbjct: 138 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 197
Query: 262 LLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTK 321
+ S IP + + ++ + + +T V+ + + C + P +RP
Sbjct: 198 VFSEGKIPYENRSN----SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFS 253
Query: 322 DLVSTLAPL 330
L+ LA +
Sbjct: 254 RLLRQLAEI 262
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 101/215 (46%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 56 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 115
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--- 231
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+
Sbjct: 116 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAG 173
Query: 232 ---NLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 174 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KDY 231
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 232 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 264
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 101/215 (46%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 55 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 114
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--- 231
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+
Sbjct: 115 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAG 172
Query: 232 ---NLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 173 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KDY 230
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 231 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 263
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C +V EYMP L +L + + +
Sbjct: 73 EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL 132
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ DL A L EN +++ FGL + G +Y+ +
Sbjct: 133 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHVVKVADFGLSR-LMTGDTYTAHAG 190
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + +S +++FG +L ++ + + P +D+ + ++
Sbjct: 191 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYDL------ 243
Query: 289 HLEGNFSSEEAT----VVFDLASRCLQYEPRERPN 319
LE + E+ V++L C ++ P +RP+
Sbjct: 244 -LEKGYRMEQPEGCPPKVYELMRACWKWSPADRPS 277
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 21/272 (7%)
Query: 72 DFIVSES-GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
D ++ E G V+ GRL+ N +AVK + PD K +F EA + + H
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNT---LVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCS 189
+ LIG C +V E + L E + L++ A ++Y
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 190 SEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYTPPEYLRN 243
S+ ++ DL A L E ++S FG+ + DG ++ + +T PE L
Sbjct: 231 SKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 244 GRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT--V 301
GR + ES ++SFG +L + S P + + + ++ G E
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPN----LSNQQTREFVEKG--GRLPCPELCPDA 343
Query: 302 VFDLASRCLQYEPRERPNTKDLVSTLAPLQNR 333
VF L +C YEP +RP+ + L ++ R
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 105/249 (42%), Gaps = 32/249 (12%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDT 156
N+ +A+K + A + + F +EA + KL H +L L G C + LV E+M +
Sbjct: 30 NKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 157 LAKHLFHWENQTIEWAMRLRVALYIAEA-----LDYCSS-----EGRPLYHDLNAYRVLF 206
L+ +L R + L+ AE LD C E ++ DL A L
Sbjct: 89 LSDYL------------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 136
Query: 207 DENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLD 261
EN ++S FG+ + D + S+ + + PE R + +S ++SFG ++ +
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 196
Query: 262 LLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTK 321
+ S IP + ++ + + +T V+ + + C + P +RP
Sbjct: 197 VFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 252
Query: 322 DLVSTLAPL 330
L+ LA +
Sbjct: 253 RLLRQLAEI 261
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 65 LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN 119
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ + ++ D+ +L G+ +++ FG ++ + + L Y PPE +
Sbjct: 120 ALSYCHSK-KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI 178
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEAT 300
GR+ E V ++S G + + L GK PP A + S +E F
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGK--PPFEA----NTYQDTYKRISRVEFTFPDFVTE 231
Query: 301 VVFDLASRCLQYEPRERPNTKDLV 324
DL SR L++ P +RP ++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVL 255
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 105/249 (42%), Gaps = 32/249 (12%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDT 156
N+ +A+K + A + + F +EA + KL H +L L G C + LV E+M +
Sbjct: 28 NKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86
Query: 157 LAKHLFHWENQTIEWAMRLRVALYIAEA-----LDYCSS-----EGRPLYHDLNAYRVLF 206
L+ +L R + L+ AE LD C E ++ DL A L
Sbjct: 87 LSDYL------------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134
Query: 207 DENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLD 261
EN ++S FG+ + D + S+ + + PE R + +S ++SFG ++ +
Sbjct: 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 194
Query: 262 LLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTK 321
+ S IP + ++ + + +T V+ + + C + P +RP
Sbjct: 195 VFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 250
Query: 322 DLVSTLAPL 330
L+ LA +
Sbjct: 251 RLLRQLAEI 259
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 59.3 bits (142), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 106/249 (42%), Gaps = 32/249 (12%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDT 156
N+ +A+K + A + + F +EA + KL H +L L G C + LV E+M +
Sbjct: 33 NKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91
Query: 157 LAKHLFHWENQTIEWAMRLRVALYIAEA-----LDYCSS-----EGRPLYHDLNAYRVLF 206
L+ +L R + L+ AE LD C E ++ DL A L
Sbjct: 92 LSDYL------------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139
Query: 207 DENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLD 261
EN ++S FG+ + D + S+ + + PE R + +S ++SFG ++ +
Sbjct: 140 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199
Query: 262 LLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTK 321
+ S IP + + ++ + + +T V+ + + C + P +RP
Sbjct: 200 VFSEGKIPYENRSN----SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFS 255
Query: 322 DLVSTLAPL 330
L+ LA +
Sbjct: 256 RLLRQLAEI 264
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 49/216 (22%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK-------NSRDGK 227
L +A I+ A++Y + ++ DL A L EN +++ FGL + + G
Sbjct: 119 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 177
Query: 228 SYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 178 KFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KD 233
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 234 YRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 267
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/215 (22%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 300 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 359
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ +L A L EN +++ FGL + G +Y+ +
Sbjct: 360 LYMATQISSAMEYLEKKNF-IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 417
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 418 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KDY 475
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 476 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 508
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/215 (22%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
L +A I+ A++Y + ++ +L A L EN +++ FGL + G +Y+ +
Sbjct: 321 LYMATQISSAMEYLEKKNF-IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAG 378
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
+ +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KDY 436
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 437 RMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 469
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/216 (22%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + +++H L L+G C ++ E+M L +L Q + +
Sbjct: 55 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL 114
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK-------NSRDGK 227
L +A I+ A++Y + ++ DL A L EN +++ FGL + + G
Sbjct: 115 LYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 173
Query: 228 SYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + +T PE L + + +S +++FG +L ++ + + P +D+ + +L D
Sbjct: 174 KFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYELLE-KD 229
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+E E V++L C Q+ P +RP+ ++
Sbjct: 230 YRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 263
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 53/229 (23%), Positives = 108/229 (47%), Gaps = 13/229 (5%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK K + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 245 VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 303
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ +L A L EN +++ FGL
Sbjct: 304 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNF-IHRNLAARNCLVGENHLVKVADFGLS 362
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHAL 274
+ G +Y+ + + +T PE L + + +S +++FG +L ++ + + P +
Sbjct: 363 R-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 420
Query: 275 DMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
D+ + +L D +E E V++L C Q+ P +RP+ ++
Sbjct: 421 DLSQVYELLE-KDYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 466
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 33 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 88 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 144
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 145 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 259
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 260 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 299
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/234 (22%), Positives = 106/234 (45%), Gaps = 23/234 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 39 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 98 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 156
Query: 221 KNSRDGKSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP----- 269
+ G +++ + + +T PE L + + +S +++FG +L ++ + P
Sbjct: 157 R-LMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215
Query: 270 PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
PS +++ D +E E V++L C Q+ P +RP+ ++
Sbjct: 216 PSQVYELLEK-------DYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 260
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 16 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 71 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 127
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 128 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 242
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 243 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 43 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 98 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 154
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 155 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 269
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 270 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 309
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/249 (22%), Positives = 104/249 (41%), Gaps = 32/249 (12%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDT 156
N+ +A+K + + + F +EA + KL H +L L G C + LV E+M +
Sbjct: 50 NKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 108
Query: 157 LAKHLFHWENQTIEWAMRLRVALYIAEA-----LDYCSS-----EGRPLYHDLNAYRVLF 206
L+ +L R + L+ AE LD C E ++ DL A L
Sbjct: 109 LSDYL------------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 156
Query: 207 DENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLD 261
EN ++S FG+ + D + S+ + + PE R + +S ++SFG ++ +
Sbjct: 157 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 216
Query: 262 LLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTK 321
+ S IP + ++ + + +T V+ + + C + P +RP
Sbjct: 217 VFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 272
Query: 322 DLVSTLAPL 330
L+ LA +
Sbjct: 273 RLLRQLAEI 281
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V EYM N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGF-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 30/251 (11%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + K F EA + L+H+ + G C +GD ++V EYM + L K
Sbjct: 46 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 161 L-FHWENQT----------IEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
L H + + + L +A IA + Y +S+ ++ DL L EN
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGEN 164
Query: 210 GDPRLSCFGLMKNS------RDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLL 263
++ FG+ ++ R G + + PPE + + T ES ++S G VL ++
Sbjct: 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224
Query: 264 S-GKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATV---VFDLASRCLQYEPRERPN 319
+ GK P + L N +++ +G T V++L C Q EP R N
Sbjct: 225 TYGKQ--PWYQLS----NN--EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKN 276
Query: 320 TKDLVSTLAPL 330
K + + L L
Sbjct: 277 IKGIHTLLQNL 287
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/268 (21%), Positives = 116/268 (43%), Gaps = 22/268 (8%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
++ E G VV G+ + D +AVK K +F EA + KL H +L
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYD----VAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGR 193
G C +V EY+ N L +L + +E + L + + E + + S +
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESH-Q 124
Query: 194 PLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-----LAYTPPEYLRNGRVTP 248
++ DL A L D + ++S FG+ + D + S+ + ++ PE + +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 249 ESVIFSFGTVLLDLLSGKHIP---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDL 305
+S +++FG ++ ++ S +P +++ +++ L HL + ++ +
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD-------TIYQI 237
Query: 306 ASRCLQYEPRERPNTKDLVSTLAPLQNR 333
C P +RP + L+S++ PL+ +
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLREK 265
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/235 (22%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 39 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 98 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 156
Query: 221 K-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP---- 269
+ + G + + +T PE L + + +S +++FG +L ++ + P
Sbjct: 157 RLMTGDTXTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 214
Query: 270 -PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
PS +++ D +E E V++L C Q+ P +RP+ ++
Sbjct: 215 DPSQVYELLEK-------DYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 260
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP--- 237
I + LDY SE R ++ D+ A VL E GD +L+ FG+ D + TP
Sbjct: 125 ILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 238 -PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSS 296
PE ++ ++ I+S G ++L G+ PP+ L +R +L L+ +
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGE--PPNSDLHPMR---VLFLIPKNSPPTLEG 238
Query: 297 EEATVVFDLASRCLQYEPRERPNTKDLV 324
+ + + CL +PR RP K+L+
Sbjct: 239 QHSKPFKEFVEACLNKDPRFRPTAKELL 266
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 52/235 (22%), Positives = 104/235 (44%), Gaps = 25/235 (10%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+AVK + + ++F EA + +++H L L+G C ++ E+M L +
Sbjct: 39 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 97
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
L Q + + L +A I+ A++Y + ++ DL A L EN +++ FGL
Sbjct: 98 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLS 156
Query: 221 K-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP---- 269
+ + G + + +T PE L + + +S +++FG +L ++ + P
Sbjct: 157 RLMTGDTXTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 214
Query: 270 -PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDL 323
PS +++ D +E E V++L C Q+ P +RP+ ++
Sbjct: 215 DPSQVYELLEK-------DYRMERPEGCPEK--VYELMRACWQWNPSDRPSFAEI 260
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 26 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 84 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 144 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 255
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 256 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 56.2 bits (134), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 59/255 (23%), Positives = 109/255 (42%), Gaps = 27/255 (10%)
Query: 90 RLQDGNDNRRW---------IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCC 140
RL +G W +A+K K P+ F +EA + KL+H +L L Y
Sbjct: 16 RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 141 DGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDL 199
+E + +V EYM +L L E + ++ + +A +A + Y ++ DL
Sbjct: 73 VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY-IHRDL 131
Query: 200 NAYRVLFDENGDPRLSCFGLMK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVI 252
+ +L +++ FGL + +R G + + +T PE GR T +S +
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFP--IKWTAPEAALYGRFTIKSDV 189
Query: 253 FSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQY 312
+SFG +L +L++ +P + + +L ++ + + +L C +
Sbjct: 190 WSFGILLTELVTKGRVP----YPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKK 245
Query: 313 EPRERPNTKDLVSTL 327
+P ERP + L S L
Sbjct: 246 DPEERPTFEYLQSFL 260
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 69 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELAN 123
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L NG+ +++ FG ++ + + L Y PPE +
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI 182
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHA 273
GR+ E V ++S G + + L G +PP A
Sbjct: 183 -EGRMHDEKVDLWSLGVLCYEFLVG--MPPFEA 212
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE--- 183
LRH + L GY D L+ EY P T+ + L Q + R A YI E
Sbjct: 69 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELAN 123
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK--SYSTNLAYTPPEYL 241
AL YC S+ R ++ D+ +L NG+ +++ FG ++ + + L Y PPE +
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 182
Query: 242 RNGRVTPESV-IFSFGTVLLDLLSGKHIPPSHA 273
GR+ E V ++S G + + L G +PP A
Sbjct: 183 -EGRMHDEKVDLWSLGVLCYEFLVG--MPPFEA 212
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP--- 237
I + LDY SE + ++ D+ A VL E+G+ +L+ FG+ D + TP
Sbjct: 113 ILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 171
Query: 238 -PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH----LEG 292
PE ++ ++ I+S G ++L G+ PP L ++ +L L+ + LEG
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGE--PPHSELHPMK---VLFLIPKNNPPTLEG 226
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
N+S + + CL EP RP K+L+ L+N
Sbjct: 227 NYSKP----LKEFVEACLNKEPSFRPTAKELLKHKFILRN 262
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 46 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 102
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 103 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 161
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 162 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ + E ++ L C + P +RP L S
Sbjct: 220 MTNPEVIQNLERGYRMVRPDNCPEE----------LYQLMRLCWKERPEDRPTFDYLRSV 269
Query: 327 L 327
L
Sbjct: 270 L 270
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 48 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 104
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 105 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 163
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 164 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ + E ++ L C + P +RP L S
Sbjct: 222 MTNPEVIQNLERGYRMVRPDNCPEE----------LYQLMRLCWKERPEDRPTFDYLRSV 271
Query: 327 L 327
L
Sbjct: 272 L 272
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 40 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 96
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 156 ARLIEDAEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 214 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 327 L 327
L
Sbjct: 264 L 264
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 50 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 106
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 107 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 165
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 166 ARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ + E ++ L C + P +RP L S
Sbjct: 224 MTNPEVIQNLERGYRMVRPDNCPEE----------LYQLMRLCWKERPEDRPTFDYLRSV 273
Query: 327 L 327
L
Sbjct: 274 L 274
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 35 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 91
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 92 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 150
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 151 ARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 209 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 258
Query: 327 L 327
L
Sbjct: 259 L 259
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP--- 237
I + LDY SE + ++ D+ A VL E+G+ +L+ FG+ D + TP
Sbjct: 128 ILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 186
Query: 238 -PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH----LEG 292
PE ++ ++ I+S G ++L G+ PP L ++ +L L+ + LEG
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE--PPHSELHPMK---VLFLIPKNNPPTLEG 241
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
N+S + + CL EP RP K+L+ L+N
Sbjct: 242 NYSKP----LKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 49 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 105
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 106 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 164
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 165 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ + E ++ L C + P +RP L S
Sbjct: 223 MTNPEVIQNLERGYRMVRPDNCPEE----------LYQLMRLCWKERPEDRPTFDYLRSV 272
Query: 327 L 327
L
Sbjct: 273 L 273
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 26 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 84 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 144 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 255
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 256 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 25 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 83 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 143 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 254
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 255 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 46 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 102
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 103 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 161
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 162 ARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 220 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 269
Query: 327 L 327
L
Sbjct: 270 L 270
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 23 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 80
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 81 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 141 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 200 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 252
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 253 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 40 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 96
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 156 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ + E ++ L C + P +RP L S
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEE----------LYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 327 L 327
L
Sbjct: 264 L 264
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 45 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 101
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 102 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 160
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 161 ARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 219 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 268
Query: 327 L 327
L
Sbjct: 269 L 269
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 19 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 77 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 137 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 248
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 249 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 41 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 97
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 98 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 156
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 157 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 215 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 264
Query: 327 L 327
L
Sbjct: 265 L 265
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP--- 237
I + LDY SE + ++ D+ A VL E+G+ +L+ FG+ D + TP
Sbjct: 113 ILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 171
Query: 238 -PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH----LEG 292
PE ++ ++ I+S G ++L G+ PP L ++ +L L+ + LEG
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGE--PPHSELHPMK---VLFLIPKNNPPTLEG 226
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
N+S + + CL EP RP K+L+ L+N
Sbjct: 227 NYSKP----LKEFVEACLNKEPSFRPTAKELLKHKFILRN 262
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 150 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 261
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 55.5 bits (132), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 42 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 98
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 99 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 157
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 158 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 216 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 265
Query: 327 L 327
L
Sbjct: 266 L 266
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 25 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 83 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 143 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 254
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 255 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 40 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 96
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 156 ARLIEDNEXTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 214 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 327 L 327
L
Sbjct: 264 L 264
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 40 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 96
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ DL A +L + +++ FGL
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 156 ARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ N E ++ L C + P +RP L S
Sbjct: 214 MTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 327 L 327
L
Sbjct: 264 L 264
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP--- 237
I + LDY SE + ++ D+ A VL E+G+ +L+ FG+ D + TP
Sbjct: 133 ILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 238 -PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH----LEG 292
PE ++ ++ I+S G ++L G+ PP L ++ +L L+ + LEG
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGE--PPHSELHPMK---VLFLIPKNNPPTLEG 246
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
N+S + + CL EP RP K+L+ L+N
Sbjct: 247 NYSKP----LKEFVEACLNKEPSFRPTAKELLKHKFILRN 282
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V E M N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMG-AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 16 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V E M N +L L + Q I+ LR I
Sbjct: 71 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 127
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 128 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 242
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 243 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKH-AWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 21 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 78
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + KL H+ + IG R ++ E M L L +Q
Sbjct: 79 LDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 139 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 252
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + ++ D
Sbjct: 35 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDE 92
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 93 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 153 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 266
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 35 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 92
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + KL H+ + IG R ++ E M L L +Q
Sbjct: 93 LDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 153 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 266
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 60/273 (21%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 54 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 172 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 283
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++F+L C QY P+ RP+ +++S++
Sbjct: 284 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 25/280 (8%)
Query: 67 NNFSSDFIVS--ESGEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWG 123
N S D +V E GE V GRL+ + +A+K + + F EA
Sbjct: 45 TNISIDKVVGAGEFGE-----VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 124 VGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYI 181
+G+ H + L G ++V E M N +L L + Q I+ LR I
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GI 156
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LA 234
A + Y S G ++ DL A +L + N ++S FGL + D +Y+T +
Sbjct: 157 ASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 235 YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
+T PE + + T S ++S+G VL +++S P + ++++ +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVIKAVDEGYRLPP 271
Query: 295 SSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+ ++ L C Q + RP + +VS L L P
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 127 LRHKRLANLIGYCCD--GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEA 184
L H+ + G C + G+ L+ E++P+ +L ++L +N+ I +L+ A+ I +
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKG 138
Query: 185 LDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST-------NLAYTP 237
+DY S + ++ DL A VL + ++ FGL K K T + +
Sbjct: 139 MDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSG------------KHIPPSHALDMIRGKNILHL 285
PE L + S ++SFG L +LL+ K I P+H + L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG-----QMTVTRL 252
Query: 286 MDSHLEG-------NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+++ EG N E V+ L +C +++P R + ++L+ L
Sbjct: 253 VNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 127 LRHKRLANLIGYCCD--GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEA 184
L H+ + G C + G+ L+ E++P+ +L ++L +N+ I +L+ A+ I +
Sbjct: 68 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKG 126
Query: 185 LDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST-------NLAYTP 237
+DY S + ++ DL A VL + ++ FGL K K T + +
Sbjct: 127 MDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSG------------KHIPPSHALDMIRGKNILHL 285
PE L + S ++SFG L +LL+ K I P+H + L
Sbjct: 186 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG-----QMTVTRL 240
Query: 286 MDSHLEG-------NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+++ EG N E V+ L +C +++P R + ++L+ L
Sbjct: 241 VNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGFEAL 288
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAK 159
+AVK K P F EA + +L+H+RL L Y E + ++ EYM N +L
Sbjct: 36 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVD 92
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
L + L +A IAE + + E ++ +L A +L + +++ FGL
Sbjct: 93 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRNLRAANILVSDTLSCKIADFGL 151
Query: 220 MK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP--- 269
+ +R+G + + +T PE + G T +S ++SFG +L ++++ IP
Sbjct: 152 ARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209
Query: 270 ---PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVST 326
P ++ RG ++ + E ++ L C + P +RP L S
Sbjct: 210 MTNPEVIQNLERGYRMVRPDNCPEE----------LYQLMRLCWKERPEDRPTFDYLRSV 259
Query: 327 L 327
L
Sbjct: 260 L 260
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/273 (21%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 17 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 75 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A + E+ ++ FG+ ++ R G + +
Sbjct: 135 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 246
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++ +L C QY P+ RP+ +++S++
Sbjct: 247 PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 35 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 92
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 93 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 153 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 266
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 37 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 94
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 95 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 154
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 155 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 268
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 269 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 325
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 20 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 138 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 251
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKH-AWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 47 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 104
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 105 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 164
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 165 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 278
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 279 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 335
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 20 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 138 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 251
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 12 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 69
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 70 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 129
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 130 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 243
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 244 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 300
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTK-HAWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 38 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 95
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 96 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 155
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 156 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 269
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 270 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 326
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKH-AWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 21 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 78
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 79 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 139 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 252
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKH-AWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 61 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 179 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 292
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 60/278 (21%), Positives = 124/278 (44%), Gaps = 42/278 (15%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAM-------------RLRVA 178
+ L+G G L++ E M L +L +++ AM +++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL-----RSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 179 LYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTN 232
IA+ + Y ++ + ++ DL A + E+ ++ FG+ ++ R G
Sbjct: 145 GEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 233 LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEG 292
+ + PE L++G T S ++SFG VL ++ + P +G + ++ +EG
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEG 256
Query: 293 NFSSEEAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++F+L C QY P+ RP+ +++S++
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 53.1 bits (126), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/278 (21%), Positives = 124/278 (44%), Gaps = 42/278 (15%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 22 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAM-------------RLRVA 178
+ L+G G L++ E M L +L +++ AM +++A
Sbjct: 80 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL-----RSLRPAMANNPVLAPPSLSKMIQMA 134
Query: 179 LYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTN 232
IA+ + Y ++ + ++ DL A + E+ ++ FG+ ++ R G
Sbjct: 135 GEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 233 LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEG 292
+ + PE L++G T S ++SFG VL ++ + P +G + ++ +EG
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEG 246
Query: 293 NFSSEEAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++F+L C QY P+ RP+ +++S++
Sbjct: 247 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 53.1 bits (126), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKH-AWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 27 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 84
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 85 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 144
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD---- 225
AM L VA IA Y E ++ D+ A L G R++ G +RD
Sbjct: 145 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 226 -----GKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 258
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 259 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 315
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 53.1 bits (126), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN R++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 13/256 (5%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIG 137
GE VY+G + + +AVK K D K+ F EA + L H + LIG
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 138 YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
+ + ++ E P L +L +N + L +L I +A+ Y S ++
Sbjct: 81 -IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAMAYLESIN-CVHR 137
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP-----PEYLRNGRVTPESVI 252
D+ +L +L FGL + D Y ++ P PE + R T S +
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 253 FSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQY 312
+ F + ++LS P + K+++ +++ V++ L +RC Y
Sbjct: 198 WMFAVCMWEILSFGKQP----FFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDY 253
Query: 313 EPRERPNTKDLVSTLA 328
+P +RP +LV +L+
Sbjct: 254 DPSDRPRFTELVCSLS 269
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 13/256 (5%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIG 137
GE VY+G + + +AVK K D K+ F EA + L H + LIG
Sbjct: 33 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 92
Query: 138 YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
+ + ++ E P L +L +N + L +L I +A+ Y S ++
Sbjct: 93 -IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAMAYLESIN-CVHR 149
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP-----PEYLRNGRVTPESVI 252
D+ +L +L FGL + D Y ++ P PE + R T S +
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 253 FSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQY 312
+ F + ++LS P + K+++ +++ V++ L +RC Y
Sbjct: 210 WMFAVCMWEILSFGKQP----FFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDY 265
Query: 313 EPRERPNTKDLVSTLA 328
+P +RP +LV +L+
Sbjct: 266 DPSDRPRFTELVCSLS 281
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 60/259 (23%), Positives = 109/259 (42%), Gaps = 18/259 (6%)
Query: 86 VYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
V GRL+ +A+K + + F EA +G+ H + +L G
Sbjct: 38 VCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKP 97
Query: 145 RLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
++V EYM N +L L + Q I+ LR I+ + Y S G ++ DL A
Sbjct: 98 VMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYLSDMGY-VHRDLAAR 153
Query: 203 RVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LAYTPPEYLRNGRVTPESVIFSF 255
+L + N ++S FGL + D +Y+T + +T PE + + T S ++S+
Sbjct: 154 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSY 213
Query: 256 GTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPR 315
G V+ +++S P + ++++ ++ + ++ L C Q E
Sbjct: 214 GIVMWEVVSYGERPYWE----MTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERN 269
Query: 316 ERPNTKDLVSTLAPLQNRP 334
RP ++V+ L L P
Sbjct: 270 SRPKFDEIVNMLDKLIRNP 288
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 13/256 (5%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIG 137
GE VY+G + + +AVK K D K+ F EA + L H + LIG
Sbjct: 17 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 76
Query: 138 YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
+ + ++ E P L +L +N + L +L I +A+ Y S ++
Sbjct: 77 -IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAMAYLESIN-CVHR 133
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP-----PEYLRNGRVTPESVI 252
D+ +L +L FGL + D Y ++ P PE + R T S +
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 253 FSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQY 312
+ F + ++LS P + K+++ +++ V++ L +RC Y
Sbjct: 194 WMFAVCMWEILSFGKQP----FFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDY 249
Query: 313 EPRERPNTKDLVSTLA 328
+P +RP +LV +L+
Sbjct: 250 DPSDRPRFTELVCSLS 265
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 38/287 (13%)
Query: 77 ESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLAN 134
E GE A V+ + ++ +AVK + + + F EA + L+H+ +
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 135 LIGYCCDGDERLLVAEYMPNDTL----------AKHLFHWENQT---IEWAMRLRVALYI 181
G C +G L+V EYM + L AK L E+ + L VA +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A + Y + ++ DL L + ++ FG+ ++ R G + +
Sbjct: 168 AAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLS-GK----HIPPSHALDMI-RGKNILHLMDSH 289
PPE + + T ES ++SFG VL ++ + GK + + A+D I +G+ +
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP 286
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
E V+ + C Q EP++R + KD+ + L L P V
Sbjct: 287 PE----------VYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 38/287 (13%)
Query: 77 ESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLAN 134
E GE A V+ + ++ +AVK + + + F EA + L+H+ +
Sbjct: 19 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 135 LIGYCCDGDERLLVAEYMPNDTL----------AKHLFHWENQT---IEWAMRLRVALYI 181
G C +G L+V EYM + L AK L E+ + L VA +
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A + Y + ++ DL L + ++ FG+ ++ R G + +
Sbjct: 139 AAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLS-GK----HIPPSHALDMI-RGKNILHLMDSH 289
PPE + + T ES ++SFG VL ++ + GK + + A+D I +G+ +
Sbjct: 198 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP 257
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
E V+ + C Q EP++R + KD+ + L L P V
Sbjct: 258 PE----------VYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 18 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 76
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 77 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ DL A + + ++ FG+ ++ R G + +
Sbjct: 137 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 248
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P+ RP ++V+ L
Sbjct: 249 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 21 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 80 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ DL A + + ++ FG+ ++ R G + +
Sbjct: 140 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 251
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P+ RP ++V+ L
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 38/287 (13%)
Query: 77 ESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLAN 134
E GE A V+ + ++ +AVK + + + F EA + L+H+ +
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 135 LIGYCCDGDERLLVAEYMPNDTL----------AKHLFHWENQT---IEWAMRLRVALYI 181
G C +G L+V EYM + L AK L E+ + L VA +
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A + Y + ++ DL L + ++ FG+ ++ R G + +
Sbjct: 145 AAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLS-GK----HIPPSHALDMI-RGKNILHLMDSH 289
PPE + + T ES ++SFG VL ++ + GK + + A+D I +G+ +
Sbjct: 204 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP 263
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
E V+ + C Q EP++R + KD+ + L L P V
Sbjct: 264 PE----------VYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 300
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 29/238 (12%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAM 173
+ F E + L H + IG D+RL + EY+ TL + ++Q W+
Sbjct: 52 RTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQ 109
Query: 174 RLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL-------------- 219
R+ A IA + Y S ++ DLN++ L EN + ++ FGL
Sbjct: 110 RVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 220 --MKNSRDGKSYST--NLAYTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGKHIPPSH-A 273
+K K Y+ N + PE + NGR E V +FSFG VL +++ + P +
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227
Query: 274 LDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQ 331
M G N+ +D + N F + RC +P +RP+ L L L+
Sbjct: 228 RTMDFGLNVRGFLDRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 86 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 146 LVSCTYQLARGMEYLASQ-KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 264
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 265 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 300
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 23/226 (10%)
Query: 127 LRHKRLANLIGYCCDGDER--LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEA 184
L H+ + G C D E+ LV EY+P +L +L +I A L A I E
Sbjct: 73 LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEG 129
Query: 185 LDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY-------STNLAYTP 237
+ Y S+ ++ +L A VL D + ++ FGL K +G Y + + +
Sbjct: 130 MAYLHSQ-HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLS---GKHIPPSHALDMI---RGK-NILHLMDSHL 290
PE L+ + S ++SFG L +LL+ PP+ L++I +G+ +L L +
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 291 EGNFSSEEATV---VFDLASRCLQYEPRERPNTKDLVSTLAPLQNR 333
G V+ L C + E RP ++L+ L + +
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 294
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 52.4 bits (124), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 62/268 (23%), Positives = 113/268 (42%), Gaps = 15/268 (5%)
Query: 75 VSESGEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKRL 132
V G A VYKG + +G + +A+K + P +F DEA + + H L
Sbjct: 20 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 133 ANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEG 192
L+G C + LV + MP+ L +++ H I + L + IA+ + Y E
Sbjct: 80 VRLLGVCLSPTIQ-LVTQLMPHGCLLEYV-HEHKDNIGSQLLLNWCVQIAKGMMYL-EER 136
Query: 193 RPLYHDLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEY-----LRNGRV 246
R ++ DL A VL +++ FGL + D K Y+ + P ++ + +
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 247 TPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLA 306
T +S ++S+G + +L++ P D I + I L++ V+ +
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKP----YDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 252
Query: 307 SRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+C + RP K+L + + + P
Sbjct: 253 VKCWMIDADSRPKFKELAAEFSRMARDP 280
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 62/268 (23%), Positives = 113/268 (42%), Gaps = 15/268 (5%)
Query: 75 VSESGEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKRL 132
V G A VYKG + +G + +A+K + P +F DEA + + H L
Sbjct: 43 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 133 ANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEG 192
L+G C + LV + MP+ L +++ H I + L + IA+ + Y E
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLLEYV-HEHKDNIGSQLLLNWCVQIAKGMMYL-EER 159
Query: 193 RPLYHDLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEY-----LRNGRV 246
R ++ DL A VL +++ FGL + D K Y+ + P ++ + +
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 247 TPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLA 306
T +S ++S+G + +L++ P D I + I L++ V+ +
Sbjct: 220 THQSDVWSYGVTIWELMTFGGKP----YDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 275
Query: 307 SRCLQYEPRERPNTKDLVSTLAPLQNRP 334
+C + RP K+L + + + P
Sbjct: 276 VKCWMIDADSRPKFKELAAEFSRMARDP 303
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 62/260 (23%), Positives = 110/260 (42%), Gaps = 18/260 (6%)
Query: 86 VYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
V GRL+ +A+K + + F EA +G+ H + +L G G
Sbjct: 59 VCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKP 118
Query: 145 RLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
++V E+M N L L + Q I+ LR IA + Y + G ++ DL A
Sbjct: 119 VMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYLADMGY-VHRDLAAR 174
Query: 203 RVLFDENGDPRLSCFGLMKNSRDGKS--YSTN-----LAYTPPEYLRNGRVTPESVIFSF 255
+L + N ++S FGL + D Y+T + +T PE ++ + T S ++S+
Sbjct: 175 NILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSY 234
Query: 256 GTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPR 315
G V+ +++S P DM ++++ ++ + + L C Q E
Sbjct: 235 GIVMWEVMSYGERP---YWDM-SNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERA 290
Query: 316 ERPNTKDLVSTLAPLQNRPD 335
ERP + +V L + P+
Sbjct: 291 ERPKFEQIVGILDKMIRNPN 310
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 26/297 (8%)
Query: 58 SLADLRAATNNFSSDFIVSESGEKAPNVVYKGRLQD--GNDNRRWIAVKKFTKH-AWPDP 114
S++DL+ + ++ G A VY+G++ + + +AVK + + D
Sbjct: 21 SISDLKEVPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 78
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE---NQTIEW 171
F EA + K H+ + IG R ++ E M L L +Q
Sbjct: 79 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 172 AMR--LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSC---FGLMKN---- 222
AM L VA IA Y E ++ D+ A L G R++ FG+ ++
Sbjct: 139 AMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 223 --SRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRG 279
R G + + PPE G T ++ +SFG +L ++ S ++P PS +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N 252
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDV 336
+ +L + S + V+ + ++C Q++P +RPN ++ + PDV
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 91 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 151 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 269
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 270 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 305
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L E +E++
Sbjct: 92 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 152 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 271 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 101 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 156
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 217 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 272
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 273 AEMRPSFSELVSRISAI 289
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWE----------NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 52.0 bits (123), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 20 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 78
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 79 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ DL A + + ++ FG+ ++ R G + +
Sbjct: 139 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 250
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P+ RP ++V+ L
Sbjct: 251 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 43 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 103 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 158
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 219 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 274
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 275 AEMRPSFSELVSRISAI 291
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 46 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 106 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 161
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 222 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 277
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 278 AEMRPSFSELVSRISAI 294
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 45 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 105 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 160
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 221 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 276
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 277 AEMRPSFSELVSRISAI 293
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 46 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 106 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 161
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 222 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 277
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 278 AEMRPSFSELVSRISAI 294
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 21 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 80 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ DL A + + ++ FG+ ++ R G + +
Sbjct: 140 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 251
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P+ RP ++V+ L
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 64 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 123
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 124 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 179
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 180 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 239
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 240 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 295
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 296 AEMRPSFSELVSRISAI 312
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 44 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 104 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 159
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 220 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 275
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 276 AEMRPSFSELVSRISAI 292
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/258 (23%), Positives = 109/258 (42%), Gaps = 18/258 (6%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIG 137
G+ VVY G D NR A+K ++ + F E + L H + LIG
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 138 YCC--DGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
+G +L+ D L N T++ + L +A ++Y + E + +
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYLA-EQKFV 146
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVT 247
+ DL A + DE+ +++ FGL ++ D + YS + +T E L+ R T
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 248 PESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLAS 307
+S ++SFG +L +LL+ + PP +D ++ H + ++ +
Sbjct: 207 TKSDVWSFGVLLWELLT-RGAPPYRHIDPF---DLTHFLAQGRRLPQPEYCPDSLYQVMQ 262
Query: 308 RCLQYEPRERPNTKDLVS 325
+C + +P RP + LV
Sbjct: 263 QCWEADPAVRPTFRVLVG 280
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 21 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 80 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ DL A + + ++ FG+ ++ R G + +
Sbjct: 140 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 251
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P+ RP ++V+ L
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 65 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 124
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 125 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 180
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 181 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 240
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 241 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 296
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 297 AEMRPSFSELVSRISAI 313
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 88 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 148 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 266
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 267 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 302
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP--- 237
I + LDY SE + ++ D+ A VL E GD +L+ FG+ D + TP
Sbjct: 129 ILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 187
Query: 238 -PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH----LEG 292
PE ++ ++ I+S G ++L G+ PP+ + +R +L L+ + L G
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGE--PPNSDMHPMR---VLFLIPKNNPPTLVG 242
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
+F+ + CL +P RP K+L+
Sbjct: 243 DFTKSFKEFI----DACLNKDPSFRPTAKELL 270
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 38 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 97
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 98 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 153
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + YS + + + E L+ + T +S ++
Sbjct: 154 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 213
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 214 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 269
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 270 AEMRPSFSELVSRISAI 286
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 205 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 323
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 324 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 359
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 59/273 (21%), Positives = 121/273 (44%), Gaps = 32/273 (11%)
Query: 77 ESGEKAPNVVY----KGRLQDGNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRHKR 131
E G+ + +VY KG ++D + R +A+K + A + +F +EA + +
Sbjct: 19 ELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLF----HWENQTI----EWAMRLRVALYIAE 183
+ L+G G L++ E M L +L EN + + +++A IA+
Sbjct: 77 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 184 ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAYTP 237
+ Y ++ + ++ DL A E+ ++ FG+ ++ R G + +
Sbjct: 137 GMAYLNA-NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSE 297
PE L++G T S ++SFG VL ++ + P +G + ++ +EG +
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNEQVLRFVMEGGLLDK 248
Query: 298 EAT---VVFDLASRCLQYEPRERPNTKDLVSTL 327
++ +L C QY P+ RP+ +++S++
Sbjct: 249 PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 23/226 (10%)
Query: 127 LRHKRLANLIGYCCDGDER--LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEA 184
L H+ + G C D E+ LV EY+P +L +L +I A L A I E
Sbjct: 73 LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEG 129
Query: 185 LDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY-------STNLAYTP 237
+ Y ++ ++ +L A VL D + ++ FGL K +G Y + + +
Sbjct: 130 MAYLHAQ-HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 238 PEYLRNGRVTPESVIFSFGTVLLDLLS---GKHIPPSHALDMI---RGK-NILHLMDSHL 290
PE L+ + S ++SFG L +LL+ PP+ L++I +G+ +L L +
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 291 EGNFSSEEATV---VFDLASRCLQYEPRERPNTKDLVSTLAPLQNR 333
G V+ L C + E RP ++L+ L + +
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 294
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 21 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 80 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ DL A + + ++ FG+ ++ R G + +
Sbjct: 140 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 251
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P RP ++V+ L
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 16/224 (7%)
Query: 116 QFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWEN--QTIEWAM 173
+F E + +LRH + +G +V EY+ +L + L H + ++
Sbjct: 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERR 138
Query: 174 RLRVALYIAEALDYCSSEGRPLYH-DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
RL +A +A+ ++Y + P+ H DL + +L D+ ++ FGL + S
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX 198
Query: 233 LAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
A TP PE LR+ +S ++SFG +L +L + + P L+ + +
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ--PWGNLNPAQVVAAVGFKCK 256
Query: 289 HLE--GNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
LE N + + A ++ C EP +RP+ ++ L PL
Sbjct: 257 RLEIPRNLNPQVAAII----EGCWTNEPWKRPSFATIMDLLRPL 296
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 28/227 (12%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
+ F +EA + L+H +L L + ++ EYM +L L E +
Sbjct: 53 QAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL 112
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK-------NSRDGK 227
+ + IAE + Y + ++ DL A VL E+ +++ FGL + +R+G
Sbjct: 113 IDFSAQIAEGMAYIERKNY-IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 171
Query: 228 SYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + +T PE + G T +S ++SFG +L ++++ IP G+ +M
Sbjct: 172 KFP--IKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP-------YPGRTNADVMT 222
Query: 288 SHLEG-------NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ +G N E ++D+ C + + ERP L S L
Sbjct: 223 ALSQGYRMPRVENCPDE----LYDIMKMCWKEKAEERPTFDYLQSVL 265
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 29/246 (11%)
Query: 96 DNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPND 155
+N +AVK K + F +EA + L+H +L L + ++ E+M
Sbjct: 34 NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKG 92
Query: 156 TLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLS 215
+L L E + + + IAE + Y + ++ DL A VL E+ +++
Sbjct: 93 SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY-IHRDLRAANVLVSESLMCKIA 151
Query: 216 CFGLMK-------NSRDGKSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHI 268
FGL + +R+G + + +T PE + G T +S ++SFG +L ++++ I
Sbjct: 152 DFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKI 209
Query: 269 PPSHALDMIRGKNILHLMDSHLEG-------NFSSEEATVVFDLASRCLQYEPRERPNTK 321
P G+ +M + +G N E ++D+ C + + ERP
Sbjct: 210 P-------YPGRTNADVMSALSQGYRMPRMENCPDE----LYDIMKMCWKEKAEERPTFD 258
Query: 322 DLVSTL 327
L S L
Sbjct: 259 YLQSVL 264
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 159
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + + PE L + + S ++SFG VL +L +
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 321 KDL 323
+DL
Sbjct: 280 RDL 282
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E++
Sbjct: 92 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSR--DGKSYST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ D +T
Sbjct: 152 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 271 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 43 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ +L +L + ++ FG
Sbjct: 103 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRNLATRNILVENENRVKIGDFG 160
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K Y + + + PE L + + S ++SFG VL +L +
Sbjct: 161 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 220
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 221 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 280
Query: 321 KDL 323
+DL
Sbjct: 281 RDL 283
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 16/224 (7%)
Query: 116 QFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWEN--QTIEWAM 173
+F E + +LRH + +G +V EY+ +L + L H + ++
Sbjct: 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERR 138
Query: 174 RLRVALYIAEALDYCSSEGRPLYH-DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
RL +A +A+ ++Y + P+ H +L + +L D+ ++ FGL + S +
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 233 LAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
A TP PE LR+ +S ++SFG +L +L + + P L+ + +
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ--PWGNLNPAQVVAAVGFKCK 256
Query: 289 HLE--GNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
LE N + + A ++ C EP +RP+ ++ L PL
Sbjct: 257 RLEIPRNLNPQVAAII----EGCWTNEPWKRPSFATIMDLLRPL 296
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 66/302 (21%), Positives = 125/302 (41%), Gaps = 36/302 (11%)
Query: 57 FSLADLRAATNNFSSDFIVS-----------ESGEKAPNVVYKGRLQDGNDNRRWIAVKK 105
F+ D A F+ + +S E GE V G L+ ++A+K
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGE-----VCSGHLKLPGKREIFVAIKT 68
Query: 106 F-TKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW 164
+ + + F EA +G+ H + +L G +++ E+M N +L L
Sbjct: 69 LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 128
Query: 165 ENQ--TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN 222
+ Q I+ LR IA + Y + ++ DL A +L + N ++S FGL +
Sbjct: 129 DGQFTVIQLVGMLR---GIAAGMKYLADMNY-VHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 223 SRDGKS---YSTNLA------YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHA 273
D S Y++ L +T PE ++ + T S ++S+G V+ +++S P
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---Y 241
Query: 274 LDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNR 333
DM +++++ ++ + + + L C Q + RP +V+TL +
Sbjct: 242 WDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 300
Query: 334 PD 335
P+
Sbjct: 301 PN 302
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E++
Sbjct: 84 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 144 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 262
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 263 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 298
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E++
Sbjct: 81 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 141 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 259
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 260 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 295
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 59/268 (22%), Positives = 116/268 (43%), Gaps = 24/268 (8%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFT-------KHAWPDPKQFADEAWGVGKLRHKR 131
G+ +V+KGRL ++ +A+K ++F E + + L H
Sbjct: 28 GKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSE 191
+ L G + +V E++P L L + I+W+++LR+ L IA ++Y ++
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 192 GRPLYH-DL---NAYRVLFDENGD--PRLSCFGLMKNSRDGKS-YSTNLAYTPPEYL--R 242
P+ H DL N + DEN +++ FGL + S S N + PE +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAE 201
Query: 243 NGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVV 302
T ++ +SF +L +L+G+ ++ I+ N++ + L + +
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--EEGLRPTIPEDCPPRL 259
Query: 303 FDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ C +P++RP+ +V L+ L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKELSEL 287
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E++
Sbjct: 92 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 152 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 271 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E++
Sbjct: 85 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 145 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 263
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 264 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 299
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + +L+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 99 KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + L+G C ++ EY L ++L + ++ N+ E M +
Sbjct: 99 KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ Y L ++L + ++ N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 55/240 (22%), Positives = 101/240 (42%), Gaps = 29/240 (12%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E+
Sbjct: 92 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 152 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVPSYVMLGIP 345
MD N ++E ++ + C P +RP K LV L + Y+ L +P
Sbjct: 271 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMP 324
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 73 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 133 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 190
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 191 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 251 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 321 KDL 323
+DL
Sbjct: 311 RDL 313
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E+
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 137 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 256 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 64/272 (23%), Positives = 116/272 (42%), Gaps = 25/272 (9%)
Query: 75 VSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ--FADEAWGVGKLRHKRL 132
V E GE V GRL+ +A+K K + D ++ F EA +G+ H +
Sbjct: 39 VGEFGE-----VCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 133 ANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSS 190
+L G +++ EYM N +L L + + I+ LR I + Y S
Sbjct: 93 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS- 148
Query: 191 EGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LAYTPPEYLRN 243
+ ++ DL A +L + N ++S FG+ + D +Y+T + +T PE +
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 244 GRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVF 303
+ T S ++S+G V+ +++S P DM ++++ ++ + +
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERP---YWDM-SNQDVIKAIEEGYRLPPPMDCPIALH 264
Query: 304 DLASRCLQYEPRERPNTKDLVSTLAPLQNRPD 335
L C Q E +RP +V+ L L P+
Sbjct: 265 QLMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 296
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+HK + NL+G C ++ EY L ++L +E++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY--ST 231
+ A +A ++Y +S+ + ++ DL A VL E+ +++ FGL ++ Y +T
Sbjct: 193 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG +L ++ L G P ++ + H
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 312 MDK--PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 347
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 46 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 106 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 163
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 164 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 223
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 224 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 283
Query: 321 KDL 323
+DL
Sbjct: 284 RDL 286
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 177 VALYIAE---ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYS- 230
V Y+AE ALD+ S G +Y DL +L DE G +L+ FGL K S D K+YS
Sbjct: 129 VKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 231 -TNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG 265
+ Y PE + T + +SFG ++ ++L+G
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL---------FHWE-NQTIEWAMRLR- 176
+HK + NL+G C ++ Y L ++L + ++ N+ E M +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 177 ---VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK--NSRDGKSYST 231
+A ++Y +S+ + ++ DL A VL EN +++ FGL + N+ D +T
Sbjct: 159 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 232 N----LAYTPPEYLRNGRVTPESVIFSFGTVLLDL--LSGKHIPPSHALDMIRGKNILHL 285
N + + PE L + T +S ++SFG ++ ++ L G P ++ + H
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
MD N ++E ++ + C P +RP K LV L
Sbjct: 278 MDK--PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 48 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 108 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 165
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 166 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 225
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 226 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 285
Query: 321 KDL 323
+DL
Sbjct: 286 RDL 288
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 47 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 107 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 164
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 165 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 224
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 225 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 284
Query: 321 KDL 323
+DL
Sbjct: 285 RDL 287
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 40 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 100 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 157
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 158 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 217
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 218 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 277
Query: 321 KDL 323
+DL
Sbjct: 278 RDL 280
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 55/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 45 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + Y +S+ + ++ DL A
Sbjct: 105 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAA 160
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 221 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 276
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 277 AEMRPSFSELVSRISAI 293
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 20/234 (8%)
Query: 101 IAVKKFTKHAW-PDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAK 159
+A+K K+ D + E + LRH+ + L ++ +V EY P L
Sbjct: 38 VAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFD 97
Query: 160 HLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL 219
++ +++ E R+ V I A+ Y S+G + DL +LFDE +L FGL
Sbjct: 98 YIIS-QDRLSEEETRV-VFRQIVSAVAYVHSQGYA-HRDLKPENLLFDEYHKLKLIDFGL 154
Query: 220 MKNSRDGKSYST-----NLAYTPPEYLR-NGRVTPESVIFSFGTVLLDLLSGKHIPPSHA 273
+ K Y +LAY PE ++ + E+ ++S G +L L+ G +P
Sbjct: 155 CAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCG-FLP---- 209
Query: 274 LDMIRGKNILHLMDSHLEGNFSSEE--ATVVFDLASRCLQYEPRERPNTKDLVS 325
N++ L + G + + + L + LQ +P++R + K+L++
Sbjct: 210 ---FDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLN 260
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 177 VALYIAE---ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYS- 230
V Y+AE ALD+ S G +Y DL +L DE G +L+ FGL K S D K+YS
Sbjct: 128 VKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 231 -TNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG 265
+ Y PE + T + +SFG ++ ++L+G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 49 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 109 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 166
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 167 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 226
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 227 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 286
Query: 321 KDL 323
+DL
Sbjct: 287 RDL 289
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 105 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 162
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 223 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
Query: 321 KDL 323
+DL
Sbjct: 283 RDL 285
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 41 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 101 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 158
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 159 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 218
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 219 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 278
Query: 321 KDL 323
+DL
Sbjct: 279 RDL 281
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 159
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 321 KDL 323
+DL
Sbjct: 280 RDL 282
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 64/253 (25%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 101 IAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIGYCCD-GDERL-LVAEYMPNDTL 157
+AVK A P + + E + L H+ + G C D G L LV EY+P +L
Sbjct: 63 VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 158 AKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCF 217
+L +I A L A I E + Y ++ ++ DL A VL D + ++ F
Sbjct: 123 RDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 218 GLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKH 267
GL K +G + + + PE L+ + S ++SFG L +LL+
Sbjct: 179 GLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238
Query: 268 IPPSHALDMI---RGK-NILHLMDSHLEGN---FSSEEATVVFDLASRCLQYEPRERPNT 320
PP+ L++I +G+ +L L + G + V+ L C + E RP
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF 298
Query: 321 KDLVSTLAPLQNR 333
++L+ L + +
Sbjct: 299 ENLIPILKTVHEK 311
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 177 VALYIAE---ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYS- 230
V Y+AE ALD+ S G +Y DL +L DE G +L+ FGL K S D K+YS
Sbjct: 128 VKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 231 -TNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG 265
+ Y PE + T + +SFG ++ ++L+G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 60 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 120 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 177
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 237
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 238 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 297
Query: 321 KDL 323
+DL
Sbjct: 298 RDL 300
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 159
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 321 KDL 323
+DL
Sbjct: 280 RDL 282
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 60/275 (21%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 22 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 80
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 81 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ +L A + + ++ FG+ ++ R G + +
Sbjct: 141 ADGMAYLNAK-KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 252
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P RP ++V+ L
Sbjct: 253 DQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 60 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 120 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 177
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 237
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 238 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 297
Query: 321 KDL 323
+DL
Sbjct: 298 RDL 300
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 60/275 (21%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 74 IVSESGEKAPNVVYKGRLQD---GNDNRRWIAVKKFTKHAWPDPK-QFADEAWGVGKLRH 129
++ E G+ + +VY+G +D G R +AVK + A + +F +EA +
Sbjct: 21 LLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 130 KRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR--------LRVALYI 181
+ L+G G L+V E M + L +L + R +++A I
Sbjct: 80 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN------SRDGKSYSTNLAY 235
A+ + Y +++ + ++ +L A + + ++ FG+ ++ R G + +
Sbjct: 140 ADGMAYLNAK-KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 236 TPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
PE L++G T S ++SFG VL ++ S P +G + ++ ++G +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-------YQGLSNEQVLKFVMDGGYL 251
Query: 296 SEEATV---VFDLASRCLQYEPRERPNTKDLVSTL 327
+ V DL C Q+ P RP ++V+ L
Sbjct: 252 DQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ EY+P +L
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
+L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 105 DYL-QAHAERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 162
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 223 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
Query: 321 KDL 323
+DL
Sbjct: 283 RDL 285
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 30/193 (15%)
Query: 101 IAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAK 159
+AVK + A D + F EA + + + + L+G C G L+ EYM L +
Sbjct: 80 VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 160 HLFHWENQTI----------------------EWAMRLRVALYIAEALDYCSSEGRPLYH 197
L T+ A +L +A +A + Y SE + ++
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHR 198
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYTPPEYLRNGRVTPESV 251
DL L EN +++ FGL +N Y + + + PPE + R T ES
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 252 IFSFGTVLLDLLS 264
++++G VL ++ S
Sbjct: 259 VWAYGVVLWEIFS 271
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ-TIEWAM 173
+ F EA +G+ H + L G G ++V EYM N +L L + Q TI M
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---M 151
Query: 174 RLRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYS 230
+L L + + Y S G ++ DL A VL D N ++S FGL + D +Y+
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGY-VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 231 TN-----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS 264
T + +T PE + + S ++SFG V+ ++L+
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 75 VSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ--FADEAWGVGKLRHKRL 132
V E GE V GRL+ +A+K K + D ++ F EA +G+ H +
Sbjct: 24 VGEFGE-----VCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 133 ANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSS 190
+L G +++ EYM N +L L + + I+ LR I + Y S
Sbjct: 78 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSD 134
Query: 191 EGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LAYTPPEYLRN 243
++ DL A +L + N ++S FG+ + D +Y+T + +T PE +
Sbjct: 135 MSY-VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 244 GRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVF 303
+ T S ++S+G V+ +++S P DM ++++ ++ + +
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERP---YWDM-SNQDVIKAIEEGYRLPPPMDCPIALH 249
Query: 304 DLASRCLQYEPRERPNTKDLVSTLAPLQNRPD 335
L C Q E +RP +V+ L L P+
Sbjct: 250 QLMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 281
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 52/243 (21%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTLA 158
+AVKK + F E + L+H + G C R L+ E++P +L
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 159 KHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG 218
++L + I+ L+ I + ++Y ++ R ++ DL +L + ++ FG
Sbjct: 105 EYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG 162
Query: 219 LMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS---GKHI 268
L K K + + + PE L + + S ++SFG VL +L +
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 269 PPSHALDMI----RGKNILHLMDSHLEGNFSSEE----ATVVFDLASRCLQYEPRERPNT 320
PP+ + MI +G+ I+ + L+ N ++ + + C +RP+
Sbjct: 223 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
Query: 321 KDL 323
+DL
Sbjct: 283 RDL 285
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 75 VSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ--FADEAWGVGKLRHKRL 132
V E GE V GRL+ +A+K K + D ++ F EA +G+ H +
Sbjct: 18 VGEFGE-----VCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 133 ANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSS 190
+L G +++ EYM N +L L + + I+ LR I + Y S
Sbjct: 72 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSD 128
Query: 191 EGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG--KSYSTN-----LAYTPPEYLRN 243
++ DL A +L + N ++S FG+ + D +Y+T + +T PE +
Sbjct: 129 MSY-VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 244 GRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVF 303
+ T S ++S+G V+ +++S P DM ++++ ++ + +
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERP---YWDM-SNQDVIKAIEEGYRLPPPMDCPIALH 243
Query: 304 DLASRCLQYEPRERPNTKDLVSTLAPLQNRPD 335
L C Q E +RP +V+ L L P+
Sbjct: 244 QLMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 275
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 62/262 (23%), Positives = 113/262 (43%), Gaps = 22/262 (8%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTK-HAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
V +GRL+ +A+K + ++F EA +G+ H + L G +
Sbjct: 30 VCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMP 89
Query: 145 RLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
+++ E+M N L L + Q I+ LR IA + Y + E ++ DL A
Sbjct: 90 VMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLA-EMSYVHRDLAAR 145
Query: 203 RVLFDENGDPRLSCFGLMK----NSRDGKSYSTNLA------YTPPEYLRNGRVTPESVI 252
+L + N ++S FGL + NS D +Y+++L +T PE + + T S
Sbjct: 146 NILVNSNLVCKVSDFGLSRFLEENSSD-PTYTSSLGGKIPIRWTAPEAIAFRKFTSASDA 204
Query: 253 FSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQY 312
+S+G V+ +++S P DM +++++ ++ + T + L C Q
Sbjct: 205 WSYGIVMWEVMSFGERP---YWDM-SNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQK 260
Query: 313 EPRERPNTKDLVSTLAPLQNRP 334
+ RP +VS L + P
Sbjct: 261 DRNARPRFPQVVSALDKMIRNP 282
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 44/296 (14%)
Query: 68 NFSSDFIVSESGEKAPNVVYKGRL--QDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGV 124
+ S+ + E GE VYKG L + + +A+K A P ++F EA
Sbjct: 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 83
Query: 125 GKLRHKRLANLIG-------------YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEW 171
+L+H + L+G YC GD + P+ + +++T++
Sbjct: 84 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD---DDRTVKS 140
Query: 172 AMR----LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK 227
A+ + + IA ++Y SS ++ DL VL + + ++S GL +
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 199
Query: 228 SYST------NLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-----PSHALDM 276
Y + + PE + G+ + +S I+S+G VL ++ S P ++M
Sbjct: 200 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259
Query: 277 IRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
IR + +L D + V+ L C P RP KD+ S L N
Sbjct: 260 IRNRQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 44/296 (14%)
Query: 68 NFSSDFIVSESGEKAPNVVYKGRL--QDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGV 124
+ S+ + E GE VYKG L + + +A+K A P ++F EA
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 125 GKLRHKRLANLIG-------------YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEW 171
+L+H + L+G YC GD + P+ + +++T++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD---DDRTVKS 123
Query: 172 AMR----LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK 227
A+ + + IA ++Y SS ++ DL VL + + ++S GL +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 228 SYST------NLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-----PSHALDM 276
Y + + PE + G+ + +S I+S+G VL ++ S P ++M
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 277 IRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
IR + +L D + V+ L C P RP KD+ S L N
Sbjct: 243 IRNRQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/268 (21%), Positives = 115/268 (42%), Gaps = 24/268 (8%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFT-------KHAWPDPKQFADEAWGVGKLRHKR 131
G+ +V+KGRL ++ +A+K ++F E + + L H
Sbjct: 28 GKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSE 191
+ L G + +V E++P L L + I+W+++LR+ L IA ++Y ++
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 192 GRPLYH-DL---NAYRVLFDENGD--PRLSCFGLMKNSRDGKS-YSTNLAYTPPEYL--R 242
P+ H DL N + DEN +++ FG + S S N + PE +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIGAE 201
Query: 243 NGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVV 302
T ++ +SF +L +L+G+ ++ I+ N++ + L + +
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--EEGLRPTIPEDCPPRL 259
Query: 303 FDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ C +P++RP+ +V L+ L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKELSEL 287
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 39/282 (13%)
Query: 68 NFSSDFIVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQ--FADEAWGVG 125
NF + + SGE ++KGR Q GND I VK W K F +E +
Sbjct: 13 NFLTKLNENHSGE-----LWKGRWQ-GND----IVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 126 KLRHKRLANLIGYCCD--GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE 183
H + ++G C L+ +MP +L L N ++ + ++ AL +A
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 184 ALDYCSSEGRPLY--HDLNAYRVLFDENGDPRLSCFGLMKNSRD-GKSYSTNLAYTPPEY 240
+ + + PL H LN+ V+ DE+ R+S + + + G+ Y+ A+ PE
Sbjct: 123 GMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP--AWVAPEA 179
Query: 241 LRNGRVTPESV------IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNF 294
L+ PE ++SF +L +L++ + +P + +M G M LEG
Sbjct: 180 LQK---KPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIG------MKVALEGLR 229
Query: 295 SSEEATV---VFDLASRCLQYEPRERPNTKDLVSTLAPLQNR 333
+ + V L C+ +P +RP +V L +Q++
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/230 (20%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+A+++ P + +E + + ++ + N + GDE +V EY+ +L
Sbjct: 49 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
+ + A R L +AL++ S + ++ D+ + +L +G +L+ FG
Sbjct: 109 VTETCMDEGQIAAVCRECL---QALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFC 164
Query: 221 KNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDM 276
+S + + TP PE + P+ I+S G + ++++ G+ PP +
Sbjct: 165 AQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENP 222
Query: 277 IRGKNILHLMDSHLEGNFSS-EEATVVF-DLASRCLQYEPRERPNTKDLV 324
+R L+L+ ++ + E+ + +F D +RCL+ + +R + K+L+
Sbjct: 223 LRA---LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQ-TIEWAM 173
+ F EA +G+ H + L G G ++V EYM N +L L + Q TI M
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---M 151
Query: 174 RLRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL---MKNSRDGKSY 229
+L L + + Y S G ++ DL A VL D N ++S FGL +++ D
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGY-VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 230 STN----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS 264
+T + +T PE + + S ++SFG V+ ++L+
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYSTNL 233
+V++ + + L Y + + ++ D+ +L + G+ +L FG+ D S+
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 167
Query: 234 AYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKH-IPPSHALDMIRGK-NILHLMDSHL- 290
+Y PE L+ + +S I+S G L+++ G++ IPP A + R I L+D +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVN 227
Query: 291 -------EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
G FS E D ++CL P ER + K L+
Sbjct: 228 EPPPKLPSGVFSLEFQ----DFVNKCLIKNPAERADLKQLM 264
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/268 (21%), Positives = 115/268 (42%), Gaps = 24/268 (8%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFT-------KHAWPDPKQFADEAWGVGKLRHKR 131
G+ +V+KGRL ++ +A+K ++F E + + L H
Sbjct: 28 GKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 132 LANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSE 191
+ L G + +V E++P L L + I+W+++LR+ L IA ++Y ++
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 192 GRPLYH-DL---NAYRVLFDENGD--PRLSCFGLMKNSRDGKS-YSTNLAYTPPEYL--R 242
P+ H DL N + DEN +++ F L + S S N + PE +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIGAE 201
Query: 243 NGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVV 302
T ++ +SF +L +L+G+ ++ I+ N++ + L + +
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--EEGLRPTIPEDCPPRL 259
Query: 303 FDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ C +P++RP+ +V L+ L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKELSEL 287
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 146 LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVL 205
+ E+ TL + + + ++ + L + I + +DY S+ + ++ DL +
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLIHRDLKPSNIF 168
Query: 206 FDENGDPRLSCFGLMKNSR-DGKSYST--NLAYTPPEYLRNGRVTPESVIFSFGTVLLDL 262
+ ++ FGL+ + + DGK + L Y PE + + E +++ G +L +L
Sbjct: 169 LVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 263 LSGKHIPPSHALDMI--RGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNT 320
L H D K L D + F +E T++ L S+ +P +RPNT
Sbjct: 229 L--------HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSK----KPEDRPNT 276
Query: 321 KDLVSTLAPLQNRPD 335
+++ TL + P+
Sbjct: 277 SEILRTLTVWKKSPE 291
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 47/230 (20%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+A+++ P + +E + + ++ + N + GDE +V EY+ +L
Sbjct: 48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
+ + A R L +AL++ S + ++ D+ + +L +G +L+ FG
Sbjct: 108 VTETCMDEGQIAAVCRECL---QALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 221 KNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDM 276
+S + + TP PE + P+ I+S G + ++++ G+ PP +
Sbjct: 164 AQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENP 221
Query: 277 IRGKNILHLMDSHLEGNFSS-EEATVVF-DLASRCLQYEPRERPNTKDLV 324
+R L+L+ ++ + E+ + +F D +RCL+ + +R + K+L+
Sbjct: 222 LRA---LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 20/261 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTK-HAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
V +GRL+ +A+K + ++F EA +G+ H + L G +
Sbjct: 32 VCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMP 91
Query: 145 RLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
+++ E+M N L L + Q I+ LR IA + Y + E ++ DL A
Sbjct: 92 VMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLA-EMSYVHRDLAAR 147
Query: 203 RVLFDENGDPRLSCFGLMK----NSRDGKSYST-----NLAYTPPEYLRNGRVTPESVIF 253
+L + N ++S FGL + NS D S+ + +T PE + + T S +
Sbjct: 148 NILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAW 207
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
S+G V+ +++S P DM +++++ ++ + T + L C Q +
Sbjct: 208 SYGIVMWEVMSFGERP---YWDM-SNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKD 263
Query: 314 PRERPNTKDLVSTLAPLQNRP 334
RP +VS L + P
Sbjct: 264 RNARPRFPQVVSALDKMIRNP 284
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/262 (21%), Positives = 112/262 (42%), Gaps = 20/262 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
V G L+ ++A+K + + + F EA +G+ H + +L G
Sbjct: 23 VCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 82
Query: 145 RLLVAEYMPNDTLAKHLFHWENQ--TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
+++ E+M N +L L + Q I+ LR IA + Y + ++ L A
Sbjct: 83 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLADMNY-VHRALAAR 138
Query: 203 RVLFDENGDPRLSCFGLMKNSRDGKS---YSTNLA------YTPPEYLRNGRVTPESVIF 253
+L + N ++S FGL + D S Y++ L +T PE ++ + T S ++
Sbjct: 139 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 198
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
S+G V+ +++S P DM +++++ ++ + + + L C Q +
Sbjct: 199 SYGIVMWEVMSYGERP---YWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKD 254
Query: 314 PRERPNTKDLVSTLAPLQNRPD 335
RP +V+TL + P+
Sbjct: 255 RNHRPKFGQIVNTLDKMIRNPN 276
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 41/276 (14%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKL-RHKRLANLI 136
GE V K R++ + R A+K+ ++A D + FA E + KL H + NL+
Sbjct: 34 GEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHL-----------FHWENQT---IEWAMRLRVALYIA 182
G C L EY P+ L L F N T + L A +A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYT 236
+DY S + + ++ DL A +L EN +++ FGL SR + Y + +
Sbjct: 153 RGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWM 208
Query: 237 PPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS-----HLE 291
E L T S ++S+G +L +++S P G L + LE
Sbjct: 209 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-------GMTCAELYEKLPQGYRLE 261
Query: 292 GNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++ V+DL +C + +P ERP+ ++ +L
Sbjct: 262 KPLNCDDE--VYDLMRQCWREKPYERPSFAQILVSL 295
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 12/221 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + + H + LIG + + ++ E L + +++ A
Sbjct: 58 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASL 115
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 116 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 174
Query: 233 ---LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ + PE + R T S ++ FG + ++L P ++ +++ +++
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENG 230
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ L ++C Y+P RP +L + L+ +
Sbjct: 231 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 46/230 (20%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+A+++ P + +E + + ++ + N + GDE +V EY+ +L
Sbjct: 49 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
+ + A R L +AL++ S + ++ ++ + +L +G +L+ FG
Sbjct: 109 VTETCMDEGQIAAVCRECL---QALEFLHS-NQVIHRNIKSDNILLGMDGSVKLTDFGFC 164
Query: 221 KNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDM 276
+S + + TP PE + P+ I+S G + ++++ G+ PP +
Sbjct: 165 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENP 222
Query: 277 IRGKNILHLMDSHLEGNFSS-EEATVVF-DLASRCLQYEPRERPNTKDLV 324
+R L+L+ ++ + E+ + +F D +RCL+ + +R + K+L+
Sbjct: 223 LRA---LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 16/223 (7%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLA--KHLFHWENQTIEWA 172
++F EA + + H + LIG + ++ M TL + +++ A
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKYSLDLA 108
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 109 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + PE + R T S ++ FG + ++L P ++ +++ ++
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIE 223
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ L ++C Y+P RP +L + L+ +
Sbjct: 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 16/223 (7%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLA--KHLFHWENQTIEWA 172
++F EA + + H + LIG + ++ M TL + +++ A
Sbjct: 56 EKFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKYSLDLA 111
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 112 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 170
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + PE + R T S ++ FG + ++L P ++ +++ ++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIE 226
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ L ++C Y+P RP +L + L+ +
Sbjct: 227 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 41/276 (14%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKL-RHKRLANLI 136
GE V K R++ + R A+K+ ++A D + FA E + KL H + NL+
Sbjct: 24 GEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHL-----------FHWENQT---IEWAMRLRVALYIA 182
G C L EY P+ L L F N T + L A +A
Sbjct: 83 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYT 236
+DY S + + ++ DL A +L EN +++ FGL SR + Y + +
Sbjct: 143 RGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWM 198
Query: 237 PPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS-----HLE 291
E L T S ++S+G +L +++S P G L + LE
Sbjct: 199 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-------GMTCAELYEKLPQGYRLE 251
Query: 292 GNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++ V+DL +C + +P ERP+ ++ +L
Sbjct: 252 KPLNCDDE--VYDLMRQCWREKPYERPSFAQILVSL 285
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 12/221 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + + H + LIG + + ++ E L + +++ A
Sbjct: 61 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASL 118
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 119 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 233 ---LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ + PE + R T S ++ FG + ++L P ++ +++ +++
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENG 233
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ L ++C Y+P RP +L + L+ +
Sbjct: 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/230 (20%), Positives = 104/230 (45%), Gaps = 15/230 (6%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+A+++ P + +E + + ++ + N + GDE +V EY+ +L
Sbjct: 48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
+ + A R L +AL++ S + ++ D+ + +L +G +L+ FG
Sbjct: 108 VTETCMDEGQIAAVCRECL---QALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 221 KNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDM 276
+S + + TP PE + P+ I+S G + ++++ G+ PP +
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENP 221
Query: 277 IRGKNILHLMDSHLEGNFSS-EEATVVF-DLASRCLQYEPRERPNTKDLV 324
+R L+L+ ++ + E+ + +F D +RCL + +R + K+L+
Sbjct: 222 LRA---LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 12/221 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + + H + LIG + + ++ E L + +++ A
Sbjct: 59 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASL 116
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 117 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 175
Query: 233 ---LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ + PE + R T S ++ FG + ++L P ++ +++ +++
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENG 231
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ L ++C Y+P RP +L + L+ +
Sbjct: 232 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 12/221 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + + H + LIG + + ++ E L + +++ A
Sbjct: 84 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASL 141
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 142 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 200
Query: 233 ---LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ + PE + R T S ++ FG + ++L P ++ +++ +++
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENG 256
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ L ++C Y+P RP +L + L+ +
Sbjct: 257 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 47/230 (20%), Positives = 104/230 (45%), Gaps = 15/230 (6%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+A+++ P + +E + + ++ + N + GDE +V EY+ +L
Sbjct: 48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 161 LFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLM 220
+ + A R L +AL++ S + ++ D+ + +L +G +L+ FG
Sbjct: 108 VTETCMDEGQIAAVCRECL---QALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 221 KNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDM 276
+S + + TP PE + P+ I+S G + ++++ G+ PP +
Sbjct: 164 AQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENP 221
Query: 277 IRGKNILHLMDSHLEGNFSS-EEATVVF-DLASRCLQYEPRERPNTKDLV 324
+R L+L+ ++ + E+ + +F D +RCL + +R + K+L+
Sbjct: 222 LRA---LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 44 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 104 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 159
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 220 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 275
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 276 AEMRPSFSELVSRISAI 292
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 46 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 106 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 161
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 222 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 277
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 278 AEMRPSFSELVSRISAI 294
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 165 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 220
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 280
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 281 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 336
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 337 AEMRPSFSELVSRISAI 353
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 43/191 (22%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
E+ TL + + + ++ + L + I + +DY S+ + + DL + +
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDT 158
Query: 210 GDPRLSCFGLMKNSR-DGKSYSTN--LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGK 266
++ FGL+ + + DGK + L Y PE + + E +++ G +L +LL
Sbjct: 159 KQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL--- 215
Query: 267 HIPPSHALDMI--RGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
H D K L D + F +E T++ L S+ +P +RPNT +++
Sbjct: 216 -----HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSK----KPEDRPNTSEIL 266
Query: 325 STLAPLQNRPD 335
TL + P+
Sbjct: 267 RTLTVWKKSPE 277
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 46 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 106 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 161
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 222 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 277
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 278 AEMRPSFSELVSRISAI 294
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 47 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 106
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 107 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 162
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 163 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 223 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 278
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 279 AEMRPSFSELVSRISAI 295
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 16/223 (7%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLA--KHLFHWENQTIEWA 172
++F EA + + H + LIG + ++ M TL + +++ A
Sbjct: 56 EKFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKYSLDLA 111
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 112 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 170
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + PE + R T S ++ FG + ++L P ++ +++ ++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIE 226
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ L ++C Y+P RP +L + L+ +
Sbjct: 227 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 24/253 (9%)
Query: 101 IAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTL 157
+AVK + P + + E + L H+ + G C D E+ LV EY+P +L
Sbjct: 40 VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 158 AKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCF 217
+L + A L A I E + Y ++ ++ L A VL D + ++ F
Sbjct: 100 RDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ-HYIHRALAARNVLLDNDRLVKIGDF 155
Query: 218 GLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS------ 264
GL K +G Y + + + PE L+ + S ++SFG L +LL+
Sbjct: 156 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ 215
Query: 265 GKHIPPSHALDMIRGK-NILHLMDSHLEGNFSSEEATV---VFDLASRCLQYEPRERPNT 320
H + + +G+ +L L + G ++ L C + E RP
Sbjct: 216 SPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTF 275
Query: 321 KDLVSTLAPLQNR 333
++LV L Q +
Sbjct: 276 QNLVPILQTAQEK 288
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/257 (21%), Positives = 115/257 (44%), Gaps = 20/257 (7%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 51 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 110
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 111 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 166
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 167 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 226
Query: 254 SFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYE 313
SFG +L +L++ + PP ++ L L+ + + ++++ +C +
Sbjct: 227 SFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP---LYEVMLKCWHPK 282
Query: 314 PRERPNTKDLVSTLAPL 330
RP+ +LVS ++ +
Sbjct: 283 AEMRPSFSELVSRISAI 299
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 24/253 (9%)
Query: 101 IAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIGYCCDGDER--LLVAEYMPNDTL 157
+AVK + P + + E + L H+ + G C D E+ LV EY+P +L
Sbjct: 41 VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 158 AKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCF 217
+L + A L A I E + Y ++ ++ L A VL D + ++ F
Sbjct: 101 RDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ-HYIHRALAARNVLLDNDRLVKIGDF 156
Query: 218 GLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS------ 264
GL K +G Y + + + PE L+ + S ++SFG L +LL+
Sbjct: 157 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ 216
Query: 265 GKHIPPSHALDMIRGK-NILHLMDSHLEGNFSSEEATV---VFDLASRCLQYEPRERPNT 320
H + + +G+ +L L + G ++ L C + E RP
Sbjct: 217 SPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTF 276
Query: 321 KDLVSTLAPLQNR 333
++LV L Q +
Sbjct: 277 QNLVPILQTAQEK 289
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 46/197 (23%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHA-WPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDE 144
VY G L D + + AVK + + QF E + H + +L+G C +
Sbjct: 47 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 106
Query: 145 R-LLVAEYMPNDTLAKHLFHWENQTIEWAMR--LRVALYIAEALDYCSSEGRPLYHDLNA 201
L+V YM + L + N+T ++ + L +A+ + + +S+ + ++ DL A
Sbjct: 107 SPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAA 162
Query: 202 YRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--------LAYTPPEYLRNGRVTPESVIF 253
+ DE +++ FGL ++ D + S + + + E L+ + T +S ++
Sbjct: 163 RNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 254 SFGTVLLDLLSGKHIPP 270
SFG +L +L++ + PP
Sbjct: 223 SFGVLLWELMT-RGAPP 238
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 6/178 (3%)
Query: 143 DERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
D LV M L H++H A + A I L+ E R +Y DL
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPE 315
Query: 203 RVLFDENGDPRLSCFGLMKNSRDG---KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVL 259
+L D++G R+S GL + +G K + Y PE ++N R T ++ G +L
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 260 LDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRER 317
++++G+ P I+ + + L+ E +S + L S+ L +P ER
Sbjct: 376 YEMIAGQS-PFQQRKKKIKREEVERLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 18/159 (11%)
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYSTNL 233
+V++ + + L Y + + ++ D+ +L + G+ +L FG+ D S+
Sbjct: 127 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 186
Query: 234 AYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHL--- 290
+Y PE L+ + +S I+S G L+++ G++ S + M I L+D +
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSM----AIFELLDYIVNEP 242
Query: 291 -----EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
G FS E D ++CL P ER + K L+
Sbjct: 243 PPKLPSGVFSLEFQ----DFVNKCLIKNPAERADLKQLM 277
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/153 (31%), Positives = 69/153 (45%), Gaps = 34/153 (22%)
Query: 86 VYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEA--WGVGKLRHKRLANLIGYCCDGD 143
VYKG L + R +AVK F+ + + + F +E + V + H +A I GD
Sbjct: 29 VYKGSLDE-----RPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIV----GD 76
Query: 144 ER---------LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSE--- 191
ER LLV EY PN +L K+L T +W R+A + L Y +E
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 192 ---GRPL--YHDLNAYRVLFDENGDPRLSCFGL 219
+P + DLN+ VL +G +S FGL
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 46/223 (20%), Positives = 91/223 (40%), Gaps = 16/223 (7%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLA--KHLFHWENQTIEWA 172
++F EA + + H + LIG + ++ M TL + +++ A
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKFSLDLA 491
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL + D Y +
Sbjct: 492 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 233 LAYTP-----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
P PE + R T S ++ FG + ++L P ++ +++ ++
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIE 606
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ L ++C Y+P RP +L + L+ +
Sbjct: 607 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 6/178 (3%)
Query: 143 DERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAY 202
D LV M L H++H A + A I L+ E R +Y DL
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPE 315
Query: 203 RVLFDENGDPRLSCFGLMKNSRDG---KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVL 259
+L D++G R+S GL + +G K + Y PE ++N R T ++ G +L
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 260 LDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRER 317
++++G+ P I+ + + L+ E +S + L S+ L +P ER
Sbjct: 376 YEMIAGQS-PFQQRKKKIKREEVERLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
K+F E +L H+ + ++I + D LV EY+ TL++++ +++ A+
Sbjct: 56 KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 175 LRVALYIAEALDYC--SSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ + LD + + R ++ D+ +L D N ++ FG+ K + TN
Sbjct: 116 -----FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 233 -----LAYTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGKHIPP 270
+ Y PE + G T E I+S G VL ++L G+ PP
Sbjct: 171 HVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGE--PP 211
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
RH + L + +V EY+ L ++ ++ +E R+ I A+D
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVD 125
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC ++ DL VL D + + +++ FGL DG+ T+ Y PE + +
Sbjct: 126 YCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI-S 183
Query: 244 GRV--TPESVIFSFGTVLLDLLSG------KHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
GR+ PE I+S G +L LL G +H+P IRG G F
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRG------------GVFY 229
Query: 296 SEEAT--VVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVPSYVM 341
E V L LQ +P +R KD+ Q D+PSY+
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ---DLPSYLF 274
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 44/218 (20%), Positives = 91/218 (41%), Gaps = 15/218 (6%)
Query: 117 FADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLR 176
F EA + L+H +L L + ++ E+M +L L E +
Sbjct: 57 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 115
Query: 177 VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK-------NSRDGKSY 229
+ IAE + + ++ DL A +L + +++ FGL + +R+G +
Sbjct: 116 FSAQIAEGMAFIEQRNY-IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 230 STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ +T PE + G T +S ++SFG +L+++++ IP + ++ ++
Sbjct: 175 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPGMSNPEVIRALERG 228
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++++ RC + P ERP + + S L
Sbjct: 229 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 266
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 206 RHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
DY SE +Y DL ++ D++G +++ FGL K +DG K++ Y PE L
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR 346
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 209 RHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 264
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
DY SE +Y DL ++ D++G +++ FGL K +DG K++ Y PE L
Sbjct: 265 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGR 349
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 41/276 (14%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKL-RHKRLANLI 136
GE V K R++ + R A+K+ ++A D + FA E + KL H + NL+
Sbjct: 31 GEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHL-----------FHWENQT---IEWAMRLRVALYIA 182
G C L EY P+ L L F N T + L A +A
Sbjct: 90 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYT 236
+DY S + + ++ +L A +L EN +++ FGL SR + Y + +
Sbjct: 150 RGMDYLSQK-QFIHRNLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWM 205
Query: 237 PPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS-----HLE 291
E L T S ++S+G +L +++S P G L + LE
Sbjct: 206 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-------GMTCAELYEKLPQGYRLE 258
Query: 292 GNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++ V+DL +C + +P ERP+ ++ +L
Sbjct: 259 KPLNCDDE--VYDLMRQCWREKPYERPSFAQILVSL 292
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 64/281 (22%), Positives = 120/281 (42%), Gaps = 44/281 (15%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFAD----EAWGVGKLRHKRLAN 134
GE + +V K R D R +A+KKF + D K E + +LRH+ L N
Sbjct: 34 GEGSYGMVMKCR---NKDTGRIVAIKKFLES--DDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 135 LIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRP 194
L+ C LV E++ + T+ L + N +++ + + I + +C S
Sbjct: 89 LLEVCKKKKRWYLVFEFV-DHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHN-I 145
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKN-SRDGKSYSTNLA---YTPPEYLRNGRVTPES 250
++ D+ +L ++G +L FG + + G+ Y +A Y PE L ++
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 251 V-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNIL----HLMDSHLE-------------G 292
V +++ G ++ ++ G+ + P + D+ + +I+ +L+ H E
Sbjct: 206 VDVWAIGCLVTEMFMGEPLFPGDS-DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 293 NFSSEE---------ATVVFDLASRCLQYEPRERPNTKDLV 324
E + VV DLA +CL +P +RP +L+
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/218 (20%), Positives = 91/218 (41%), Gaps = 15/218 (6%)
Query: 117 FADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLR 176
F EA + L+H +L L + ++ E+M +L L E +
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 177 VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMK-------NSRDGKSY 229
+ IAE + + ++ DL A +L + +++ FGL + +R+G +
Sbjct: 289 FSAQIAEGMAFIEQRNY-IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 230 STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ +T PE + G T +S ++SFG +L+++++ IP + ++ ++
Sbjct: 348 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPGMSNPEVIRALERG 401
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++++ RC + P ERP + + S L
Sbjct: 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYSTNL 233
+V++ + + L Y + + ++ D+ +L + G+ +L FG+ D +
Sbjct: 111 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTR 170
Query: 234 AYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGN 293
+Y PE L+ + +S I+S G L+++ G++ P A I L+D ++
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMA--------IFELLD-YIVNE 221
Query: 294 FSSEEATVVF-----DLASRCLQYEPRERPNTKDLV 324
+ + VF D ++CL P ER + K L+
Sbjct: 222 PPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLM 257
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/211 (20%), Positives = 89/211 (42%), Gaps = 11/211 (5%)
Query: 117 FADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLR 176
F EA + L+H +L L + ++ E+M +L L E +
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 177 VALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYT 236
+ IAE + + ++ DL A +L + +++ FGL +R G + + +T
Sbjct: 283 FSAQIAEGMAFIEQRNY-IHRDLRAANILVSASLVCKIADFGL---ARVGAKFP--IKWT 336
Query: 237 PPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSS 296
PE + G T +S ++SFG +L+++++ IP + ++ ++
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPGMSNPEVIRALERGYRMPRPE 392
Query: 297 EEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
++++ RC + P ERP + + S L
Sbjct: 393 NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 67 RHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 122
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
DY SE +Y DL ++ D++G +++ FGL K +DG K + Y PE L
Sbjct: 123 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGR 207
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 68 RHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 123
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
DY SE +Y DL ++ D++G +++ FGL K +DG K + Y PE L
Sbjct: 124 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGR 208
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 66 RHPFLTAL-KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 121
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
DY SE +Y DL ++ D++G +++ FGL K +DG K + Y PE L
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGR 206
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 21 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 80
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IAE ++Y E R L
Sbjct: 81 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAEGMNYL--EDRRL 135
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 136 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 195
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 196 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 251
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 252 CWMIDADSRPKFRELIIEFSKMARDP 277
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 62/262 (23%), Positives = 112/262 (42%), Gaps = 21/262 (8%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
IV E G+ A VYK + + A K + + + + E + H +
Sbjct: 15 IVGELGDGAFGKVYKAK---NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 71
Query: 134 NLIG-YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEG 192
L+G Y DG +++ E+ P + + + E +++ V + EAL++ S+
Sbjct: 72 KLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSK- 128
Query: 193 RPLYHDLNAYRVLFDENGDPRLSCFGL----MKNSRDGKSYSTNLAYTPPEYL--RNGRV 246
R ++ DL A VL GD RL+ FG+ +K + S+ + PE + +
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 247 TP---ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVF 303
TP ++ I+S G L+++ + PP H L+ +R +L + S + + +V F
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIE--PPHHELNPMR--VLLKIAKSDPPTLLTPSKWSVEF 244
Query: 304 -DLASRCLQYEPRERPNTKDLV 324
D L P RP+ L+
Sbjct: 245 RDFLKIALDKNPETRPSAAQLL 266
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 43/218 (19%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL------------FHWENQTIEWAMRL 175
+H+ + NL+G C G L++ EY L L F N T+ L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--- 232
+ +A+ + + +S+ ++ D+ A VL ++ FGL ++ + +Y
Sbjct: 168 HFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 233 ---LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ + PE + + T +S ++S+G +L ++ S P L + ++
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ F+ + ++ + C EP RP + + S L
Sbjct: 287 AQPAFAPKN---IYSIMQACWALEPTHRPTFQQICSFL 321
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 46/221 (20%), Positives = 94/221 (42%), Gaps = 12/221 (5%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
++F EA + + H + LIG + + ++ E L + +++ A
Sbjct: 56 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFLQVRKFSLDLASL 113
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL---MKNSRDGKSYST 231
+ A ++ AL Y S+ R ++ D+ A VL N +L FGL M++S K+
Sbjct: 114 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG 172
Query: 232 NL--AYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
L + PE + R T S ++ FG + ++L P ++ +++ +++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENG 228
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
++ L ++C Y+P RP +L + L+ +
Sbjct: 229 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 177 VALYIAE---ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRD--GKSYS- 230
V Y+AE LD+ S G +Y DL +L DE G +L+ FGL K + D K+YS
Sbjct: 132 VKFYLAELALGLDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF 190
Query: 231 -TNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSG 265
+ Y PE + + + +S+G ++ ++L+G
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/223 (19%), Positives = 91/223 (40%), Gaps = 16/223 (7%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLA--KHLFHWENQTIEWA 172
++F EA + + H + LIG + ++ M TL + +++ A
Sbjct: 56 EKFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKFSLDLA 111
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ A ++ AL Y S+ R ++ D+ A VL +L FGL + D Y +
Sbjct: 112 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKAS 170
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
+ + PE + R T S ++ FG + ++L P ++ +++ ++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIE 226
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ L ++C Y+P RP +L + L+ +
Sbjct: 227 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 62/262 (23%), Positives = 112/262 (42%), Gaps = 21/262 (8%)
Query: 74 IVSESGEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLA 133
IV E G+ A VYK + + A K + + + + E + H +
Sbjct: 23 IVGELGDGAFGKVYKAK---NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 134 NLIG-YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEG 192
L+G Y DG +++ E+ P + + + E +++ V + EAL++ S+
Sbjct: 80 KLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSK- 136
Query: 193 RPLYHDLNAYRVLFDENGDPRLSCFGL----MKNSRDGKSYSTNLAYTPPEYL--RNGRV 246
R ++ DL A VL GD RL+ FG+ +K + S+ + PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 247 TP---ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVF 303
TP ++ I+S G L+++ + PP H L+ +R +L + S + + +V F
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIE--PPHHELNPMR--VLLKIAKSDPPTLLTPSKWSVEF 252
Query: 304 -DLASRCLQYEPRERPNTKDLV 324
D L P RP+ L+
Sbjct: 253 RDFLKIALDKNPETRPSAAQLL 274
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 57/261 (21%), Positives = 108/261 (41%), Gaps = 44/261 (16%)
Query: 101 IAVKKFTKHAWP-DPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTL-- 157
+AVK ++A P + + E + ++ H + L G C LL+ EY +L
Sbjct: 56 VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 158 --------------------AKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
+ L H + + + + A I++ + Y +E + ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHR 174
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYTPPEYLRNGRVTPESV 251
DL A +L E ++S FGL ++ + SY + + E L + T +S
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 252 IFSFGTVLLDL--LSGK---HIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLA 306
++SFG +L ++ L G IPP ++++ + + D+ SEE ++ L
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDN------CSEE---MYRLM 285
Query: 307 SRCLQYEPRERPNTKDLVSTL 327
+C + EP +RP D+ L
Sbjct: 286 LQCWKQEPDKRPVFADISKDL 306
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 126 KLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALY----I 181
+L+H+ + L ++ LV E+M ND L K++ + L + Y +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 182 AEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN----SRDGKSYSTNLAYTP 237
+ L +C E + L+ DL +L ++ G +L FGL + S L Y
Sbjct: 118 LQGLAFC-HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 238 PEYLRNGRVTPESV-IFSFGTVLLDLLSGKHIPPS 271
P+ L R S+ I+S G +L ++++GK + P
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 34/228 (14%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
RH + L + +V EY+ L ++ ++ +E R+ I A+D
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVD 125
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC ++ DL VL D + + +++ FGL DG+ + Y PE + +
Sbjct: 126 YCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVI-S 183
Query: 244 GRV--TPESVIFSFGTVLLDLLSG------KHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
GR+ PE I+S G +L LL G +H+P IRG G F
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRG------------GVFY 229
Query: 296 SEEAT--VVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVPSYVM 341
E V L LQ +P +R KD+ Q D+PSY+
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ---DLPSYLF 274
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 45/223 (20%), Positives = 90/223 (40%), Gaps = 16/223 (7%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLA--KHLFHWENQTIEWA 172
++F EA + + H + LIG + ++ M TL + +++ A
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVWII----MELCTLGELRSFLQVRKFSLDLA 491
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
+ A ++ AL Y S+ R ++ D+ A VL +L FGL + D Y +
Sbjct: 492 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 233 LAYTP-----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMD 287
P PE + R T S ++ FG + ++L P ++ +++ ++
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIE 606
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ L ++C Y+P RP +L + L+ +
Sbjct: 607 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 31/233 (13%)
Query: 146 LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYHDLNAY 202
V EY+ L H+ Q+ R Y AE L + S+G +Y DL
Sbjct: 95 FFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLD 148
Query: 203 RVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTV 258
+L D++G +++ FG+ K + G + + TP PE L + +SFG +
Sbjct: 149 NILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 208
Query: 259 LLDLLSGKHIPPSHALDMIRGKNILH--LMDSHLEGNFSSEEATVVFDLASRCLQYEPRE 316
L ++L G+ P H D + + H MD+ + +EA DL + EP +
Sbjct: 209 LYEMLIGQ--SPFHGQD---EEELFHSIRMDNPFYPRWLEKEAK---DLLVKLFVREPEK 260
Query: 317 RPNTKDLVSTLAPLQNRPDVPSYVMLGIPRHEEAPPTPQHPLSPMGDACSRMD 369
R + ++ P + R E PP SP CS D
Sbjct: 261 RLGVR------GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD--CSNFD 305
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 27 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 87 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 141
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 202 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 257
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 258 CWMIDADSRPKFRELIIEFSKMARDP 283
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 26 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 86 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 140
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 201 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 256
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 257 CWMIDADSRPKFRELIIEFSKMARDP 282
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 31/233 (13%)
Query: 146 LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYHDLNAY 202
V EY+ L H+ Q+ R Y AE L + S+G +Y DL
Sbjct: 94 FFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLD 147
Query: 203 RVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTV 258
+L D++G +++ FG+ K + G + + TP PE L + +SFG +
Sbjct: 148 NILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 207
Query: 259 LLDLLSGKHIPPSHALDMIRGKNILH--LMDSHLEGNFSSEEATVVFDLASRCLQYEPRE 316
L ++L G+ P H D + + H MD+ + +EA DL + EP +
Sbjct: 208 LYEMLIGQ--SPFHGQD---EEELFHSIRMDNPFYPRWLEKEAK---DLLVKLFVREPEK 259
Query: 317 RPNTKDLVSTLAPLQNRPDVPSYVMLGIPRHEEAPPTPQHPLSPMGDACSRMD 369
R + ++ P + R E PP SP CS D
Sbjct: 260 RLGVR------GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD--CSNFD 304
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 27 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 87 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 141
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 202 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMRK 257
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 258 CWMIDADSRPKFRELIIEFSKMARDP 283
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 31 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 91 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 145
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 205
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 206 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 261
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 262 CWMIDADSRPKFRELIIEFSKMARDP 287
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 43/218 (19%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL------------FHWENQTIEWAMRL 175
+H+ + NL+G C G L++ EY L L F N T L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--- 232
+ +A+ + + +S+ ++ D+ A VL ++ FGL ++ + +Y
Sbjct: 168 HFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 233 ---LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSH 289
+ + PE + + T +S ++S+G +L ++ S P L + ++
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 290 LEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ F+ + ++ + C EP RP + + S L
Sbjct: 287 AQPAFAPKN---IYSIMQACWALEPTHRPTFQQICSFL 321
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 27 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 87 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 141
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 202 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 257
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 258 CWMIDADSRPKFRELIIEFSKMARDP 283
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 30 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 89
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 90 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 144
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 145 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 204
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 205 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 260
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 261 CWMIDADSRPKFRELIIEFSKMARDP 286
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 34 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 93
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 94 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 148
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 149 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 208
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 209 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMRK 264
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 265 CWMIDADSRPKFRELIIEFSKMARDP 290
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 31/217 (14%)
Query: 120 EAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVAL 179
E + RH + L + +V EY+ L ++ +N ++ R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQ 123
Query: 180 YIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YT 236
I +DYC ++ DL VL D + + +++ FGL DG+ + Y
Sbjct: 124 QILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYA 182
Query: 237 PPEYLRNGRV--TPESVIFSFGTVLLDLLSGK------HIPPSHALDMIRGKNILHLMDS 288
PE + +GR+ PE I+S G +L LL G H+P L
Sbjct: 183 APEVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--------------LFKK 227
Query: 289 HLEGNFSSEEAT--VVFDLASRCLQYEPRERPNTKDL 323
+G F + + V L LQ +P +R KD+
Sbjct: 228 ICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 42.0 bits (97), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 28 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 87
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 88 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 142
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 202
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 203 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 258
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 259 CWMIDADSRPKFRELIIEFSKMARDP 284
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 52/250 (20%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
+ D +G L H + L+G C G LV +Y+P +L H+ + +
Sbjct: 60 QAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLL 117
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG---LMKNSRDGKSYS- 230
L + IA+ + Y G ++ +L A VL +++ FG L+ YS
Sbjct: 118 LNWGVQIAKGMYYLEEHGM-VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 231 --TNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
T + + E + G+ T +S ++S+G + +L++ P L + ++L +
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG-AEPYAGLRLAEVPDLLEKGER 235
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVPSYVMLGIPRHE 348
+ + + V+ + +C + RP K+L + + P P Y+++ + E
Sbjct: 236 LAQPQICTID---VYMVMVKCWMIDENIRPTFKELANEFTRMARDP--PRYLVI---KRE 287
Query: 349 EAP---PTPQ 355
P P P+
Sbjct: 288 SGPGIAPGPE 297
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 84 GICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 138
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 254
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDP 280
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 18 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 77
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 78 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 132
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 193 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMARDP 274
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 84 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 138
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 254
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDP 280
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 27 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 87 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 141
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 202 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 257
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 258 CWMIDADSRPKFRELIIEFSKMARDP 283
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 49 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 108
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 109 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 163
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 164 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 223
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 224 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 279
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 280 CWMIDADSRPKFRELIIEFSKMARDP 305
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 26 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 86 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 140
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 201 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 256
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 257 CWMIDADSRPKFRELIIEFSKMARDP 282
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 25 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 84
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 85 GICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 139
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 199
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 200 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 255
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 256 CWMIDADSRPKFRELIIEFSKMARDP 281
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 129 HKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTI----------------EWA 172
H + NL+G C G L++ EY L L + I +
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
L + +A+ + + +S+ ++ DL A +L ++ FGL ++ ++ +Y
Sbjct: 162 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 233 ------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ + PE + N T ES ++S+G L +L S P P +D + +
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFYK 275
Query: 286 MDSHLEGNFSSEEATV-VFDLASRCLQYEPRERPNTKDLVSTL 327
M S E A ++D+ C +P +RP K +V +
Sbjct: 276 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 52/250 (20%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 115 KQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR 174
+ D +G L H + L+G C G LV +Y+P +L H+ + +
Sbjct: 78 QAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLL 135
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG---LMKNSRDGKSYS- 230
L + IA+ + Y G ++ +L A VL +++ FG L+ YS
Sbjct: 136 LNWGVQIAKGMYYLEEHGM-VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 231 --TNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDS 288
T + + E + G+ T +S ++S+G + +L++ P L + ++L +
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG-AEPYAGLRLAEVPDLLEKGER 253
Query: 289 HLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVPSYVMLGIPRHE 348
+ + + V+ + +C + RP K+L + + P P Y+++ + E
Sbjct: 254 LAQPQICTID---VYMVMVKCWMIDENIRPTFKELANEFTRMARDP--PRYLVI---KRE 305
Query: 349 EAP---PTPQ 355
P P P+
Sbjct: 306 SGPGIAPGPE 315
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 84 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 138
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 254
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDP 280
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 25 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 84
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 85 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 139
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 199
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 200 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 255
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 256 CWMIDADSRPKFRELIIEFSKMARDP 281
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 84 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 138
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMRK 254
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDP 280
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 16/170 (9%)
Query: 165 ENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSR 224
+ QTI + ++A+ I +AL++ S+ ++ D+ VL + G ++ FG+
Sbjct: 146 KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 205
Query: 225 DGKSYSTNLAYTPPEYLRNGRVTPE---------SVIFSFGTVLLDLLSGKHIPPSHALD 275
D + + + P Y+ R+ PE S I+S G +++L + S
Sbjct: 206 DSVAKTIDAGCKP--YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 263
Query: 276 MIRGKNILHLMDSHLEGN-FSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
+ K ++ L + FS+E D S+CL+ +ERP +L+
Sbjct: 264 FQQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPELM 309
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/220 (20%), Positives = 88/220 (40%), Gaps = 23/220 (10%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWA----------MRLRV 177
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 178 ALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN----- 232
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 150 SFQVAKGMEFLASR-KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 233 -LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMDSHL 290
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 291 EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 269 PDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 304
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
L+H + L G C LV E+ L + L + I + + A+ IA ++
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMN 119
Query: 187 YCSSEG-RPLYH-DLNAYRVLF---DENGDP-----RLSCFGLMKNSRDGKSYSTNLAYT 236
Y E P+ H DL + +L ENGD +++ FGL + S AY
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA 179
Query: 237 --PPEYLRNGRVTPESVIFSFGTVLLDLLSGK 266
PE +R + S ++S+G +L +LL+G+
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 129 HKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTI----------------EWA 172
H + NL+G C G L++ EY L L + I +
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
L + +A+ + + +S+ ++ DL A +L ++ FGL ++ ++ +Y
Sbjct: 164 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 233 ------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ + PE + N T ES ++S+G L +L S P P +D + +
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFYK 277
Query: 286 MDSHLEGNFSSEEATV-VFDLASRCLQYEPRERPNTKDLVSTL 327
M S E A ++D+ C +P +RP K +V +
Sbjct: 278 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
LRH + L DE ++V EY N+ L ++ + + + A R I A++
Sbjct: 71 LRHPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQ--IISAVE 127
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC + ++ DL +L DE+ + +++ FGL DG T+ Y PE + +
Sbjct: 128 YCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-S 185
Query: 244 GRV--TPESVIFSFGTVLLDLL 263
G++ PE ++S G +L +L
Sbjct: 186 GKLYAGPEVDVWSCGVILYVML 207
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
LRH + L DE ++V EY N+ L ++ + + + A R I A++
Sbjct: 70 LRHPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQ--IISAVE 126
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC + ++ DL +L DE+ + +++ FGL DG T+ Y PE + +
Sbjct: 127 YCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-S 184
Query: 244 GRV--TPESVIFSFGTVLLDLL 263
G++ PE ++S G +L +L
Sbjct: 185 GKLYAGPEVDVWSCGVILYVML 206
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
LRH + L DE ++V EY N+ L ++ + + + A R I A++
Sbjct: 61 LRHPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQ--IISAVE 117
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC + ++ DL +L DE+ + +++ FGL DG T+ Y PE + +
Sbjct: 118 YCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-S 175
Query: 244 GRV--TPESVIFSFGTVLLDLL 263
G++ PE ++S G +L +L
Sbjct: 176 GKLYAGPEVDVWSCGVILYVML 197
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 129 HKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTI----------------EWA 172
H + NL+G C G L++ EY L L + I +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
L + +A+ + + +S+ ++ DL A +L ++ FGL ++ ++ +Y
Sbjct: 169 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 233 ------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ + PE + N T ES ++S+G L +L S P P +D + +
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFYK 282
Query: 286 MDSHLEGNFSSEEATV-VFDLASRCLQYEPRERPNTKDLVSTL 327
M S E A ++D+ C +P +RP K +V +
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 129 HKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTI----------------EWA 172
H + NL+G C G L++ EY L L + I +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
L + +A+ + + +S+ ++ DL A +L ++ FGL ++ ++ +Y
Sbjct: 146 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 233 ------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ + PE + N T ES ++S+G L +L S P P +D + +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFYK 259
Query: 286 MDSHLEGNFSSEEATV-VFDLASRCLQYEPRERPNTKDLVSTL 327
M S E A ++D+ C +P +RP K +V +
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 126 KLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE-- 183
+++H + +LI G + L+ EY+ L L E + I M Y+AE
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGI--FMEDTACFYLAEIS 131
Query: 184 -ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDGK---SYSTNLAYTPP 238
AL + +G +Y DL ++ + G +L+ FGL K S DG ++ + Y P
Sbjct: 132 MALGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 239 EYLRNGRVTPESVIFSFGTVLLDLLSGKHIPP 270
E L +S G ++ D+L+G PP
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGA--PP 220
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
LRH + L DE ++V EY N+ L ++ + + + A R I A++
Sbjct: 65 LRHPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQ--IISAVE 121
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC + ++ DL +L DE+ + +++ FGL DG T+ Y PE + +
Sbjct: 122 YCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-S 179
Query: 244 GRV--TPESVIFSFGTVLLDLL 263
G++ PE ++S G +L +L
Sbjct: 180 GKLYAGPEVDVWSCGVILYVML 201
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/231 (21%), Positives = 96/231 (41%), Gaps = 39/231 (16%)
Query: 129 HKRLANLIGYCCDGDERLLVAEYMPNDTLAKHL-----------FHWENQ---------- 167
H+ + NL+G C L+ EY L +L +ENQ
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 168 TIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGK 227
+ + L A +A+ +++ + ++ DL A VL ++ FGL ++
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 228 SYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS-GKHIPPSHALDMIRGK 280
+Y + + PE L G T +S ++S+G +L ++ S G + P +D
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----A 282
Query: 281 NILHLMDSHLEGN---FSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLA 328
N L+ + + + +++EE ++ + C ++ R+RP+ +L S L
Sbjct: 283 NFYKLIQNGFKMDQPFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLG 330
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 129 HKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTI----------------EWA 172
H + NL+G C G L++ EY L L + I +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 173 MRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN 232
L + +A+ + + +S+ ++ DL A +L ++ FGL ++ ++ +Y
Sbjct: 169 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 233 ------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ + PE + N T ES ++S+G L +L S P P +D + +
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFYK 282
Query: 286 MDSHLEGNFSSEEATV-VFDLASRCLQYEPRERPNTKDLVSTL 327
M S E A ++D+ C +P +RP K +V +
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/220 (20%), Positives = 88/220 (40%), Gaps = 23/220 (10%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLR----------V 177
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 178 ALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN----- 232
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 150 SFQVAKGMEFLASR-KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 233 -LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMDSHL 290
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 291 EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 269 PDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 304
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 57/263 (21%), Positives = 111/263 (42%), Gaps = 19/263 (7%)
Query: 82 APNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLIGYC 139
A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+G C
Sbjct: 34 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 93
Query: 140 CDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH- 197
+ L+ + MP L ++ H +N ++ + V IA+ ++Y E R L H
Sbjct: 94 LTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRLVHR 148
Query: 198 DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TPESV 251
DL A VL +++ FGL K + K Y P +++ + T +S
Sbjct: 149 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 208
Query: 252 IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQ 311
++S+G + +L++ P D I I +++ V+ + +C
Sbjct: 209 VWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 264
Query: 312 YEPRERPNTKDLVSTLAPLQNRP 334
+ RP ++L+ + + P
Sbjct: 265 IDADSRPKFRELIIEFSKMARDP 287
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 16/129 (12%)
Query: 147 LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYHDLNAYR 203
L+ +Y+ L HL E T V +Y+ E AL++ G +Y D+
Sbjct: 136 LILDYINGGELFTHLSQRERFT-----EHEVQIYVGEIVLALEHLHKLG-IIYRDIKLEN 189
Query: 204 VLFDENGDPRLSCFGLMK-----NSRDGKSYSTNLAYTPPEYLRNGRVTPESVI--FSFG 256
+L D NG L+ FGL K + + + Y P+ +R G + + +S G
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249
Query: 257 TVLLDLLSG 265
++ +LL+G
Sbjct: 250 VLMYELLTG 258
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 15/152 (9%)
Query: 126 KLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE-- 183
+++H + +LI G + L+ EY+ L L E + I M Y+AE
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGI--FMEDTACFYLAEIS 131
Query: 184 -ALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDGK---SYSTNLAYTPP 238
AL + +G +Y DL ++ + G +L+ FGL K S DG + + Y P
Sbjct: 132 MALGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 239 EYLRNGRVTPESVIFSFGTVLLDLLSGKHIPP 270
E L +S G ++ D+L+G PP
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGA--PP 220
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 94 GNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIGYCCD-GDERL-LVAE 150
G++ +AVK+ +H+ PD ++ F E + L + G G + L LV E
Sbjct: 35 GDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 93
Query: 151 YMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENG 210
Y+P+ L + ++ + L + I + ++Y S R ++ DL A +L +
Sbjct: 94 YLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA 151
Query: 211 DPRLSCFGLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLL 263
+++ FGL K K Y + + + PE L + + +S ++SFG VL +L
Sbjct: 152 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211
Query: 264 S 264
+
Sbjct: 212 T 212
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 57/263 (21%), Positives = 112/263 (42%), Gaps = 19/263 (7%)
Query: 82 APNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLIGYC 139
A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+G C
Sbjct: 34 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 93
Query: 140 CDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH- 197
+L++ + MP L ++ H +N ++ + V IA+ ++Y E R L H
Sbjct: 94 LTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRLVHR 148
Query: 198 DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TPESV 251
DL A VL +++ FGL K + K Y P +++ + T +S
Sbjct: 149 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 208
Query: 252 IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQ 311
++S+G + +L++ P D I I +++ V+ + +C
Sbjct: 209 VWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 264
Query: 312 YEPRERPNTKDLVSTLAPLQNRP 334
+ RP ++L+ + + P
Sbjct: 265 IDADSRPKFRELIIEFSKMARDP 287
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 57/263 (21%), Positives = 111/263 (42%), Gaps = 19/263 (7%)
Query: 82 APNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLIGYC 139
A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+G C
Sbjct: 27 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 86
Query: 140 CDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH- 197
+ L+ + MP L ++ H +N ++ + V IA+ ++Y E R L H
Sbjct: 87 LTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRLVHR 141
Query: 198 DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TPESV 251
DL A VL +++ FGL K + K Y P +++ + T +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 252 IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQ 311
++S+G + +L++ P D I I +++ V+ + +C
Sbjct: 202 VWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 257
Query: 312 YEPRERPNTKDLVSTLAPLQNRP 334
+ RP ++L+ + + P
Sbjct: 258 IDADSRPKFRELIIEFSKMARDP 280
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 44/261 (16%)
Query: 101 IAVKKFTKHAWP-DPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTL-- 157
+AVK ++A P + + E + ++ H + L G C LL+ EY +L
Sbjct: 56 VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 158 --------------------AKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
+ L H + + + + A I++ + Y +E + ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHR 174
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYTPPEYLRNGRVTPESV 251
DL A +L E ++S FGL ++ + S + + E L + T +S
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 252 IFSFGTVLLDL--LSGK---HIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLA 306
++SFG +L ++ L G IPP ++++ + + D+ SEE ++ L
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDN------CSEE---MYRLM 285
Query: 307 SRCLQYEPRERPNTKDLVSTL 327
+C + EP +RP D+ L
Sbjct: 286 LQCWKQEPDKRPVFADISKDL 306
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/215 (19%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW--------ENQTIEWAMRLRVAL 179
+H+ + NL+G C G L++ EY L L + + +E L +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 180 YIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------L 233
+A+ + + +S+ ++ D+ A VL ++ FGL ++ + +Y +
Sbjct: 168 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 234 AYTPPEYLRNGRVTPESVIFSFGTVLLDLLS-GKHIPPSHALDMIRGKNILHLMDSHLEG 292
+ PE + + T +S ++S+G +L ++ S G + P ++ L+ +
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG----ILVNSKFYKLVKDGYQM 282
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++ + C EP RP + + S L
Sbjct: 283 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/215 (19%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHW--------ENQTIEWAMRLRVAL 179
+H+ + NL+G C G L++ EY L L + + +E L +
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 180 YIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------L 233
+A+ + + +S+ ++ D+ A VL ++ FGL ++ + +Y +
Sbjct: 160 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 234 AYTPPEYLRNGRVTPESVIFSFGTVLLDLLS-GKHIPPSHALDMIRGKNILHLMDSHLEG 292
+ PE + + T +S ++S+G +L ++ S G + P ++ L+ +
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG----ILVNSKFYKLVKDGYQM 274
Query: 293 NFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ ++ + C EP RP + + S L
Sbjct: 275 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 94 GNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIGYCCD-GDERL-LVAE 150
G++ +AVK+ +H+ PD ++ F E + L + G G + L LV E
Sbjct: 48 GDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106
Query: 151 YMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENG 210
Y+P+ L + ++ + L + I + ++Y S R ++ DL A +L +
Sbjct: 107 YLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA 164
Query: 211 DPRLSCFGLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLL 263
+++ FGL K K Y + + + PE L + + +S ++SFG VL +L
Sbjct: 165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
Query: 264 S 264
+
Sbjct: 225 T 225
>pdb|3SZ7|A Chain A, Crystal Structure Of The Sgt2 Tpr Domain From Aspergillus
Fumigatus
Length = 164
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 39/81 (48%), Gaps = 3/81 (3%)
Query: 407 RKRGDVAFREKEFKTAVDCYSQFIDVGTMVSPTVYARRSLCHLMCDQPDAALRDAMQAQC 466
+ G+ A KE+ A+D Y+Q + + +P + R+ + Q + A DA A
Sbjct: 15 KSEGNAAMARKEYSKAIDLYTQALSIAP-ANPIYLSNRAAAYSASGQHEKAAEDAELATV 73
Query: 467 VYPDWSTAFYMQAVALAKLDM 487
V P +S A+ + LA+ DM
Sbjct: 74 VDPKYSKAW--SRLGLARFDM 92
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 13/181 (7%)
Query: 94 GNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIG--YCCDGDERLLVAE 150
G++ +AVK+ +H+ PD ++ F E + L + G Y LV E
Sbjct: 36 GDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 94
Query: 151 YMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENG 210
Y+P+ L + ++ + L + I + ++Y S R ++ DL A +L +
Sbjct: 95 YLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA 152
Query: 211 DPRLSCFGLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLL 263
+++ FGL K K Y + + + PE L + + +S ++SFG VL +L
Sbjct: 153 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212
Query: 264 S 264
+
Sbjct: 213 T 213
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 27/224 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN- 232
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 150 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLM 286
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 269 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 308
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 27/224 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 81 HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN- 232
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 141 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLM 286
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 260 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 299
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 165 ENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSR 224
+ QTI + ++A+ I +AL++ S+ ++ D+ VL + G ++ FG+
Sbjct: 102 KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161
Query: 225 DGKSYSTNLAYTPPEYLRNGRVTPE---------SVIFSFGTVLLDLLSGKHIPPSHALD 275
D + + P Y+ R+ PE S I+S G +++L + S
Sbjct: 162 DDVAKDIDAGCKP--YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
Query: 276 MIRGKNILHLMDSHLEGN-FSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
+ K ++ L + FS+E D S+CL+ +ERP +L+
Sbjct: 220 FQQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPELM 265
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 27/224 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 81 HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN- 232
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 141 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLM 286
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 260 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 299
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 32/234 (13%)
Query: 117 FADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAK--HLFHWENQTIEWAMR 174
F +E + ++++ G + DE ++ EYM ND++ K F ++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 175 LRVALYIAEAL----DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYS 230
++V I +++ Y +E + D+ +L D+NG +LS FG + D K
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 231 TNLAY--TPPEYLRN--GRVTPESVIFSFGTVLLDLLSGKHIPPSHALDM------IRGK 280
+ Y PPE+ N + I+S G + L ++ +P S + + IR K
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSLKISLVELFNNIRTK 268
Query: 281 NILHLMD------------SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKD 322
NI + +D S NF S E D L+ P ER ++D
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI---DFLKLFLRKNPAERITSED 319
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 27/224 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN- 232
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 187 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLM 286
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 305
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 306 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 345
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+ + + P K+ DEA+ + + + + L+
Sbjct: 58 GSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLL 117
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ L + IA+ ++Y E R L
Sbjct: 118 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYL--EDRRL 172
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FGL K + K Y P +++ + T
Sbjct: 173 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 232
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 233 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 288
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 289 CWMIDADSRPKFRELIIEFSKMARDP 314
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/163 (20%), Positives = 69/163 (42%), Gaps = 12/163 (7%)
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN-- 232
+ + +A +++ SS + ++ DL A +L EN ++ FGL ++ Y
Sbjct: 202 ISYSFQVARGMEFLSSR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 233 ----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMD 287
L + PE + + + +S ++S+G +L ++ S P P +D ++ +
Sbjct: 261 TRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMD----EDFCSRLR 316
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ ++ + C +P+ERP +LV L L
Sbjct: 317 EGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 31 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ L + IA+ ++Y E R L
Sbjct: 91 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYL--EDRRL 145
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FG K + K Y P +++ + T
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 205
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 206 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 261
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 262 CWMIDADSRPKFRELIIEFSKMARDP 287
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 26/207 (12%)
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
EY N TL L H EN + R+ I EAL Y S+G ++ DL + DE+
Sbjct: 95 EYCENGTLYD-LIHSENLNQQRDEYWRLFRQILEALSYIHSQG-IIHRDLKPMNIFIDES 152
Query: 210 GDPRLSCFGLMKN-----------SRDGKSYSTNLA-------YTPPEYLR-NGRVTPES 250
+ ++ FGL KN S++ S NL Y E L G +
Sbjct: 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212
Query: 251 VIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCL 310
++S G + +++ P S ++ + L + +F + V + +
Sbjct: 213 DMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268
Query: 311 QYEPRERPNTKDLV-STLAPLQNRPDV 336
++P +RP + L+ S P++++ +V
Sbjct: 269 DHDPNKRPGARTLLNSGWLPVKHQDEV 295
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 27/223 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------L 175
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 92 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN-------SRDGKS 228
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ R G +
Sbjct: 152 XYSFQVAKGMEFLASR-KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 229 YSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMD 287
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 211 -RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 288 SHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 270 MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 308
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 26 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ L + IA+ ++Y E R L
Sbjct: 86 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYL--EDRRL 140
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FG K + K Y P +++ + T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 201 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMRK 256
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 257 CWMIDADSRPKFRELIIEFSKMARDP 282
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 41/221 (18%), Positives = 88/221 (39%), Gaps = 26/221 (11%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
+H+ + NL+G C G L++ EY L L +E++
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN- 232
L + +A+ + + +S+ ++ D+ A VL ++ FGL ++ + +Y
Sbjct: 168 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS-GKHIPPSHALDMIRGKNILHLM 286
+ + PE + + T +S ++S+G +L ++ S G + P ++ L+
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG----ILVNSKFYKLV 282
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
+ + ++ + C EP RP + + S L
Sbjct: 283 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C + L+ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 84 GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 138
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FG K + K Y P +++ + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 254
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDP 280
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 39.3 bits (90), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 51/236 (21%), Positives = 97/236 (41%), Gaps = 36/236 (15%)
Query: 96 DNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPND 155
++RR +AV KH P+ Q+ + G L ++ YC GD
Sbjct: 69 ESRREVAVLANMKH--PNIVQYRESFEENGSLYI-----VMDYCEGGD-------LFKRI 114
Query: 156 TLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLS 215
K + E+Q ++W +++ +AL + + L+ D+ + + ++G +L
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVH-------DRKILHRDIKSQNIFLTKDGTVQLG 167
Query: 216 CFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPS 271
FG+ + + TP PE N +S I++ G VL +L + K
Sbjct: 168 DFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK----- 222
Query: 272 HALDMIRGKNILHLMDSHLEGNFSSEEATVVFD---LASRCLQYEPRERPNTKDLV 324
HA + KN++ + + G+F +D L S+ + PR+RP+ ++
Sbjct: 223 HAFEAGSMKNLVLKI---ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 39.3 bits (90), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 26/207 (12%)
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
EY N TL L H EN + R+ I EAL Y S+G ++ DL + DE+
Sbjct: 95 EYCENRTLYD-LIHSENLNQQRDEYWRLFRQILEALSYIHSQG-IIHRDLKPMNIFIDES 152
Query: 210 GDPRLSCFGLMKN-----------SRDGKSYSTNLA-------YTPPEYLR-NGRVTPES 250
+ ++ FGL KN S++ S NL Y E L G +
Sbjct: 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212
Query: 251 VIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCL 310
++S G + +++ P S ++ + L + +F + V + +
Sbjct: 213 DMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268
Query: 311 QYEPRERPNTKDLV-STLAPLQNRPDV 336
++P +RP + L+ S P++++ +V
Sbjct: 269 DHDPNKRPGARTLLNSGWLPVKHQDEV 295
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 39.3 bits (90), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 26 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 86 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 140
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FG K + K Y P +++ + T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 201 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 256
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 257 CWMIDADSRPKFRELIIEFSKMARDP 282
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 28 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 87
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ + V IA+ ++Y E R L
Sbjct: 88 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--IAKGMNYL--EDRRL 142
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FG K + K Y P +++ + T
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 202
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 203 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 258
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 259 CWMIDADSRPKFRELIIEFSKMARDP 284
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 57/266 (21%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 79 GEKAPNVVYKGR-LQDGNDNRRWIAVKKFTKHAWPDP-KQFADEAWGVGKLRHKRLANLI 136
G A VYKG + +G + +A+K+ + P K+ DEA+ + + + + L+
Sbjct: 26 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 137 GYCCDGDERLLVAEYMPNDTLAKHLF-HWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
G C +L++ + MP L ++ H +N ++ L + IA+ ++Y E R L
Sbjct: 86 GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYL--EDRRL 140
Query: 196 YH-DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYSTNLAYTPPEYLRNGRV-----TP 248
H DL A VL +++ FG K + K Y P +++ + T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASR 308
+S ++S+G + +L++ P D I I +++ V+ + +
Sbjct: 201 QSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQPPICTIDVYMIMRK 256
Query: 309 CLQYEPRERPNTKDLVSTLAPLQNRP 334
C + RP ++L+ + + P
Sbjct: 257 CWMIDADSRPKFRELIIEFSKMARDP 282
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 56/261 (21%), Positives = 106/261 (40%), Gaps = 44/261 (16%)
Query: 101 IAVKKFTKHAWP-DPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTL-- 157
+AVK ++A P + + E + ++ H + L G C LL+ EY +L
Sbjct: 56 VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 158 --------------------AKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
+ L H + + + + A I++ + Y +E ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMSLVHR 174
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN------LAYTPPEYLRNGRVTPESV 251
DL A +L E ++S FGL ++ + S + + E L + T +S
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 252 IFSFGTVLLDL--LSGK---HIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLA 306
++SFG +L ++ L G IPP ++++ + + D+ SEE ++ L
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDN------CSEE---MYRLM 285
Query: 307 SRCLQYEPRERPNTKDLVSTL 327
+C + EP +RP D+ L
Sbjct: 286 LQCWKQEPDKRPVFADISKDL 306
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 10/145 (6%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
LRH + L + ++V EY + L ++ + T + R I A++
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYAGGE-LFDYIVEKKRMTEDEGRRFFQQ--IICAIE 122
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRN 243
YC + ++ DL +L D+N + +++ FGL DG T+ Y PE + N
Sbjct: 123 YCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI-N 180
Query: 244 GRV--TPESVIFSFGTVLLDLLSGK 266
G++ PE ++S G VL +L G+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 34/158 (21%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL---------MKNSRDGKSYST 231
+ E L+Y G+ ++ D+ A +L E+G +++ FG+ + ++ K++
Sbjct: 125 VLEGLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 232 NLAYTPPEYLRNGR-VTPESVIFSFGTVLLDLLSGK---HIPPSHALDMIRGKNILHLMD 287
+ PE + R ++ I+SFG ++L +G H P + M+ +N ++
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 288 SHLEGNFSSEEATVVF-DLASRCLQYEPRERPNTKDLV 324
+ ++ ++ F + S CLQ +P +RP +L+
Sbjct: 244 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 34/158 (21%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL---------MKNSRDGKSYST 231
+ E L+Y G+ ++ D+ A +L E+G +++ FG+ + ++ K++
Sbjct: 130 VLEGLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 232 NLAYTPPEYLRNGR-VTPESVIFSFGTVLLDLLSGK---HIPPSHALDMIRGKNILHLMD 287
+ PE + R ++ I+SFG ++L +G H P + M+ +N ++
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 288 SHLEGNFSSEEATVVF-DLASRCLQYEPRERPNTKDLV 324
+ ++ ++ F + S CLQ +P +RP +L+
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 45/224 (20%), Positives = 88/224 (39%), Gaps = 27/224 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWA--------------M 173
H + NL+G C G +++ E+ L+ +L N+ + +
Sbjct: 92 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 174 RLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN- 232
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 152 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 233 -----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLM 286
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 270
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 271 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 310
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 46/225 (20%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 81 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN-------SRDG 226
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ R G
Sbjct: 141 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 227 KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 200 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 259 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 299
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 46/225 (20%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN-------SRDG 226
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ R G
Sbjct: 150 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 227 KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 209 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 268 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 308
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 46/225 (20%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN-------SRDG 226
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ R G
Sbjct: 150 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 227 KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 209 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 268 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 308
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 38.5 bits (88), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 46/225 (20%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAMR------------- 174
H + NL+G C G +++ E+ L+ +L N+ + + +
Sbjct: 81 HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 175 -LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN-------SRDG 226
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ R G
Sbjct: 141 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 227 KSYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHL 285
+ L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 200 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 286 MDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 259 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 299
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 38.5 bits (88), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 52/249 (20%), Positives = 100/249 (40%), Gaps = 31/249 (12%)
Query: 92 QDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDER------ 145
+DG+ + + + K A D ++F EA + + H +A L+G +
Sbjct: 47 EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106
Query: 146 LLVAEYMPNDTLAKHL---------FHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLY 196
+++ +M + L L F+ QT+ +R + IA ++Y SS ++
Sbjct: 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTL-----VRFMVDIACGMEYLSSRNF-IH 160
Query: 197 HDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTPP------EYLRNGRVTPES 250
DL A + E+ ++ FGL + G Y A P E L + T S
Sbjct: 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHS 220
Query: 251 VIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCL 310
+++FG + ++++ P + I I + + E V+DL +C
Sbjct: 221 DVWAFGVTMWEIMTRGQTPYAG----IENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCW 276
Query: 311 QYEPRERPN 319
+P++RP+
Sbjct: 277 SADPKQRPS 285
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 13/181 (7%)
Query: 94 GNDNRRWIAVKKFTKHAWPDPKQ-FADEAWGVGKLRHKRLANLIG--YCCDGDERLLVAE 150
G++ +AVK+ +H+ PD ++ F E + L + G Y E LV E
Sbjct: 32 GDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVME 90
Query: 151 YMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENG 210
Y+P+ L + ++ + L + I + ++Y S R ++ DL A +L +
Sbjct: 91 YLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA 148
Query: 211 DPRLSCFGLMKNSRDGKSY-------STNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLL 263
+++ FGL K K + + + PE L + + +S ++SFG VL +L
Sbjct: 149 HVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208
Query: 264 S 264
+
Sbjct: 209 T 209
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 46/160 (28%), Positives = 65/160 (40%), Gaps = 26/160 (16%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYLRNGRVTPESV- 251
+Y DL +L DE+G R+S GL + K +++ Y PE L+ G S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 252 IFSFGTVLLDLLSGKHIP-------PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFD 304
FS G +L LL G H P H +D + + L DS FS E +++
Sbjct: 374 WFSLGCMLFKLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDS-----FSPELRSLLEG 427
Query: 305 LASR-------CL---QYEPRERPNTKDLVSTLAPLQNRP 334
L R CL E +E P + L + LQ P
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 467
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 46/160 (28%), Positives = 65/160 (40%), Gaps = 26/160 (16%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYLRNGRVTPESV- 251
+Y DL +L DE+G R+S GL + K +++ Y PE L+ G S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 252 IFSFGTVLLDLLSGKHIP-------PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFD 304
FS G +L LL G H P H +D + + L DS FS E +++
Sbjct: 374 WFSLGCMLFKLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDS-----FSPELRSLLEG 427
Query: 305 LASR-------CL---QYEPRERPNTKDLVSTLAPLQNRP 334
L R CL E +E P + L + LQ P
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 467
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 46/224 (20%), Positives = 90/224 (40%), Gaps = 28/224 (12%)
Query: 129 HKRLANLIGYCCD-GDERLLVAEYMPNDTLAKHLFHWENQTIEWAM-------------R 174
H + NL+G C G +++ E+ L+ +L N+ + +
Sbjct: 91 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN-------SRDGK 227
+ + +A+ +++ +S + ++ DL A +L E ++ FGL ++ R G
Sbjct: 151 ICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 228 SYSTNLAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLM 286
+ L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 210 A-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 287 DSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 269 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 308
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 46/160 (28%), Positives = 65/160 (40%), Gaps = 26/160 (16%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYLRNGRVTPESV- 251
+Y DL +L DE+G R+S GL + K +++ Y PE L+ G S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 252 IFSFGTVLLDLLSGKHIP-------PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFD 304
FS G +L LL G H P H +D + + L DS FS E +++
Sbjct: 374 WFSLGCMLFKLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDS-----FSPELRSLLEG 427
Query: 305 LASR-------CL---QYEPRERPNTKDLVSTLAPLQNRP 334
L R CL E +E P + L + LQ P
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 467
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 46/160 (28%), Positives = 65/160 (40%), Gaps = 26/160 (16%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYST--NLAYTPPEYLRNGRVTPESV- 251
+Y DL +L DE+G R+S GL + K +++ Y PE L+ G S
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 372
Query: 252 IFSFGTVLLDLLSGKHIP-------PSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFD 304
FS G +L LL G H P H +D + + L DS FS E +++
Sbjct: 373 WFSLGCMLFKLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDS-----FSPELRSLLEG 426
Query: 305 LASR-------CL---QYEPRERPNTKDLVSTLAPLQNRP 334
L R CL E +E P + L + LQ P
Sbjct: 427 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 466
>pdb|2C2L|A Chain A, Crystal Structure Of The Chip U-Box E3 Ubiquitin Ligase
pdb|2C2L|B Chain B, Crystal Structure Of The Chip U-Box E3 Ubiquitin Ligase
pdb|2C2L|C Chain C, Crystal Structure Of The Chip U-Box E3 Ubiquitin Ligase
pdb|2C2L|D Chain D, Crystal Structure Of The Chip U-Box E3 Ubiquitin Ligase
Length = 281
Score = 37.7 bits (86), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 2/107 (1%)
Query: 405 EARKRGDVAFREKEFKTAVDCYSQFIDVGTMVSPTVYARRSLCHLMCDQPDAALRDAMQA 464
E +++G+ F +++ A CY + I +V+ Y R+LC+L QP+ AL D +A
Sbjct: 6 ELKEQGNRLFVGRKYPEAAACYGRAITRNPLVA-VYYTNRALCYLKMQQPEQALADCRRA 64
Query: 465 QCVYPDWSTAFYMQAVALAKLDMHKDAADMLKEAASLEEKRQRSGRG 511
+ A + +++ + +A L+ A SL K QR G
Sbjct: 65 LELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSL-AKEQRLNFG 110
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 22/240 (9%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFA---DEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMP 153
N R+ A+K K KQ DE + + H + + G D + ++ +Y+
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 154 NDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPR 213
L L ++Q + A + AL+Y S+ +Y DL +L D+NG +
Sbjct: 90 GGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYLHSKDI-IYRDLKPENILLDKNGHIK 146
Query: 214 LSCFGLMKNSRDGKSYSTNLA-YTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIPPSH 272
++ FG K D Y PE + +SFG ++ ++L+G + P
Sbjct: 147 ITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG-YTPFYD 205
Query: 273 ALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQN 332
+ M + IL + E F V DL SR + T+DL L LQN
Sbjct: 206 SNTMKTYEKIL-----NAELRFPPFFNEDVKDLLSRLI---------TRDLSQRLGNLQN 251
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 37.4 bits (85), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 13/194 (6%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
L H + L Y D L+ EY P L K L ++ T + + +A+AL
Sbjct: 80 LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATIMEELADALM 137
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFG--LMKNSRDGKSYSTNLAYTPPEYLRNG 244
YC + + ++ D+ +L G+ +++ FG + S K+ L Y PPE + G
Sbjct: 138 YCHGK-KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI-EG 195
Query: 245 RVTPESV-IFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVF 303
R+ E V ++ G + +LL G PP + N + ++ F + T
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGN--PPFESA----SHNETYRRIVKVDLKFPASVPTGAQ 249
Query: 304 DLASRCLQYEPRER 317
DL S+ L++ P ER
Sbjct: 250 DLISKLLRHNPSER 263
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 10/189 (5%)
Query: 114 PKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAM 173
P E + +L+HK + L + LV E+ D K F N ++ +
Sbjct: 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEI 102
Query: 174 RLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN----SRDGKSY 229
+ + L +C S L+ DL +L + NG+ +L+ FGL + R +
Sbjct: 103 VKSFLFQLLKGLGFCHSRNV-LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 230 STNLAYTPPEYLRNGRVTPESV-IFSFGTVLLDLL-SGKHIPPSHALDMIRGKNILHLMD 287
L Y PP+ L ++ S+ ++S G + +L +G+ + P + +D + K I L+
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLG 220
Query: 288 SHLEGNFSS 296
+ E + S
Sbjct: 221 TPTEEQWPS 229
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 37.4 bits (85), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 62/151 (41%), Gaps = 9/151 (5%)
Query: 127 LRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALD 186
++H L L D+ V +Y+ L HL E +E R A IA AL
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAA-EIASALG 153
Query: 187 YCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLR 242
Y S +Y DL +L D G L+ FGL K + + S ++ TP PE L
Sbjct: 154 YLHSLNI-VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 243 NGRVTPESVIFSFGTVLLDLLSGKHIPPSHA 273
+ G VL ++L G +PP ++
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYG--LPPFYS 241
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 37.4 bits (85), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 30/169 (17%)
Query: 175 LRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLA 234
L + + IAEA+++ S+G ++ DL + F + ++ FGL+ + T L
Sbjct: 167 LHIFIQIAEAVEFLHSKGL-MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 235 YTPPEYLRNGRV------TPESV----------IFSFGTVLLDLLSGKHIPPSHALDMIR 278
P G+V +PE + IFS G +L +LL S + M R
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY------SFSTQMER 279
Query: 279 GKNILHLMDSHLEGNFSS---EEATVVFDLASRCLQYEPRERPNTKDLV 324
+ I + + F+ +E +V D+ S P ERP D++
Sbjct: 280 VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPS----PTERPEATDII 324
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 37.4 bits (85), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 10/138 (7%)
Query: 138 YCC--DGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPL 195
+CC D V E++ L H+ +++ + A A I AL + +G +
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGI-I 146
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDGKSYSTNLAYTPPEYLRNGRVTPESV 251
Y DL VL D G +L+ FG+ K N ++ Y PE L+ P
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVD 206
Query: 252 IFSFGTVLLDLLSGKHIP 269
++ G +L ++L G H P
Sbjct: 207 WWAMGVLLYEMLCG-HAP 223
>pdb|3Q47|B Chain B, Crystal Structure Of Tpr Domain Of Chip Complexed With
Pseudophosphorylated Smad1 Peptide
pdb|3Q49|B Chain B, Crystal Structure Of The Tpr Domain Of Chip Complexed With
Hsp70-C Peptide
pdb|3Q4A|B Chain B, Crystal Structure Of The Tpr Domain Of Chip Complexed With
Phosphorylated Smad1 Peptide
Length = 137
Score = 37.4 bits (85), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 2/107 (1%)
Query: 405 EARKRGDVAFREKEFKTAVDCYSQFIDVGTMVSPTVYARRSLCHLMCDQPDAALRDAMQA 464
E +++G+ F +++ A CY + I +V+ Y R+LC+L QP+ AL D +A
Sbjct: 11 ELKEQGNRLFVGRKYPEAAACYGRAITRNPLVA-VYYTNRALCYLKMQQPEQALADCRRA 69
Query: 465 QCVYPDWSTAFYMQAVALAKLDMHKDAADMLKEAASLEEKRQRSGRG 511
+ A + +++ + +A L+ A SL K QR G
Sbjct: 70 LELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSL-AKEQRLNFG 115
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 37.0 bits (84), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 12/203 (5%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKF-TKHAWPDPKQFADEAWGVGKLRHKRLANLIG 137
GE VYKG+ DN +A+K+ +H P E + L+H + L
Sbjct: 11 GEGTYATVYKGK-SKLTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 138 YCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
LV EY+ D L ++L N ++L + + L YC + + L+
Sbjct: 68 IIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQ-KVLHR 124
Query: 198 DLNAYRVLFDENGDPRLSCFGLMK-NSRDGKSYS---TNLAYTPPEYLRNGRVTPESV-I 252
DL +L +E G+ +L+ FGL + S K+Y L Y PP+ L + +
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDM 184
Query: 253 FSFGTVLLDLLSGKHIPPSHALD 275
+ G + ++ +G+ + P ++
Sbjct: 185 WGVGCIFYEMATGRPLFPGSTVE 207
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 21/263 (7%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFAD---EAWGVGKLRHKRLANLIGYCCDGDERLLVAEY-- 151
N +A+KK + +++ D E + KLRH G LV EY
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137
Query: 152 -MPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENG 210
+D L H Q +E A AL + L Y S ++ D+ A +L E G
Sbjct: 138 GSASDLLEVH--KKPLQEVEIAAVTHGAL---QGLAYLHSHNM-IHRDVKAGNILLSEPG 191
Query: 211 DPRLSCFGLMKNSRDGKSYSTNLAYTPPEYLR---NGRVTPESVIFSFGTVLLDLLSGKH 267
+L FG + + PE + G+ + ++S G ++L K
Sbjct: 192 LVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK- 250
Query: 268 IPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
PP ++ + + H+ + S + + CLQ P++RP ++ L+
Sbjct: 251 -PPLFNMNAMSA--LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307
Query: 328 APLQNRPDVPSYVMLGIPRHEEA 350
L+ RP P+ +M I R ++A
Sbjct: 308 FVLRERP--PTVIMDLIQRTKDA 328
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 43/228 (18%), Positives = 92/228 (40%), Gaps = 33/228 (14%)
Query: 128 RHKRLANLIGYCCDGDERLLVAEY----------------MPNDTLA-----KHLFHWEN 166
+H+ + NL+G C G L++ EY M +LA + L +
Sbjct: 93 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 167 QTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG 226
+ +E L + +A+ + + +S+ ++ D+ A VL ++ FGL ++ +
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 227 KSYSTN------LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLS-GKHIPPSHALDMIRG 279
+Y + + PE + + T +S ++S+G +L ++ S G + P ++
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG----ILVN 267
Query: 280 KNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
L+ + + ++ + C EP RP + + S L
Sbjct: 268 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 315
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 37.0 bits (84), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 12/135 (8%)
Query: 139 CCDGDERLL-VAEYMPNDTLAKHLFHWENQTI--EWAMRLRVALYIAEALDYCSSEGRPL 195
C + RL V EY+ L +FH + Q E R A I+ AL+Y G +
Sbjct: 121 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG-II 175
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMKNS-RDGKSYSTNLA---YTPPEYLRNGRVTPESV 251
Y DL VL D G +L+ +G+ K R G + ST Y PE LR
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 235
Query: 252 IFSFGTVLLDLLSGK 266
++ G ++ ++++G+
Sbjct: 236 WWALGVLMFEMMAGR 250
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 37.0 bits (84), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 21/263 (7%)
Query: 97 NRRWIAVKKFTKHAWPDPKQFAD---EAWGVGKLRHKRLANLIGYCCDGDERLLVAEYM- 152
N +A+KK + +++ D E + KLRH G LV EY
Sbjct: 39 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 153 --PNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENG 210
+D L H Q +E A AL + L Y S ++ D+ A +L E G
Sbjct: 99 GSASDLLEVH--KKPLQEVEIAAVTHGAL---QGLAYLHSHNM-IHRDVKAGNILLSEPG 152
Query: 211 DPRLSCFGLMKNSRDGKSYSTNLAYTPPEYLR---NGRVTPESVIFSFGTVLLDLLSGKH 267
+L FG + + PE + G+ + ++S G ++L K
Sbjct: 153 LVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK- 211
Query: 268 IPPSHALDMIRGKNILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTL 327
PP ++ + + H+ + S + + CLQ P++RP ++ L+
Sbjct: 212 -PPLFNMNAMSA--LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268
Query: 328 APLQNRPDVPSYVMLGIPRHEEA 350
L+ RP P+ +M I R ++A
Sbjct: 269 FVLRERP--PTVIMDLIQRTKDA 289
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 36.6 bits (83), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 141 DGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSS--EGRPLYHD 198
D + LV +Y L L +E++ E R Y+AE + S + ++ D
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF----YLAEMVIAIDSVHQLHYVHRD 200
Query: 199 LNAYRVLFDENGDPRLSCFG-LMKNSRDGKSYSTNLAYTP----PEYLR-----NGRVTP 248
+ +L D NG RL+ FG +K DG S+ TP PE L+ GR P
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILH 284
E +S G + ++L G+ + +L GK + H
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPES 250
+Y DL VL D++G+ R+S GL + G++ + A TP PE L
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 251 VIFSFGTVLLDLLSGK 266
F+ G L ++++ +
Sbjct: 371 DYFALGVTLYEMIAAR 386
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 35.8 bits (81), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPES 250
+Y DL VL D++G+ R+S GL + G++ + A TP PE L
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 251 VIFSFGTVLLDLLSGK 266
F+ G L ++++ +
Sbjct: 371 DYFALGVTLYEMIAAR 386
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 35.8 bits (81), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPES 250
+Y DL VL D++G+ R+S GL + G++ + A TP PE L
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 251 VIFSFGTVLLDLLSGK 266
F+ G L ++++ +
Sbjct: 371 DYFALGVTLYEMIAAR 386
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 35.8 bits (81), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTNLAYTP----PEYLRNGRVTPES 250
+Y DL VL D++G+ R+S GL + G++ + A TP PE L
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 251 VIFSFGTVLLDLLSGK 266
F+ G L ++++ +
Sbjct: 371 DYFALGVTLYEMIAAR 386
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 35.8 bits (81), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 21/163 (12%)
Query: 181 IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFG--LMKNSRDGKSYSTNLAYTP 237
+ A+ +C S G ++ D+ +L D G +L FG + + + Y+P
Sbjct: 148 VVAAIQHCHSRGV-VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSP 206
Query: 238 PEYL-RNGRVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFSS 296
PE++ R+ + ++S G +L D++ G + R + IL E +F +
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGD-------IPFERDQEILEA-----ELHFPA 254
Query: 297 EEATVVFDLASRCLQYEPRERPNTKDLVSTLAPLQNRP--DVP 337
+ L RCL +P RP+ ++++ L P P DVP
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEIL--LDPWMQTPAEDVP 295
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 35.8 bits (81), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 39/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 165 ENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSR 224
+ QTI + ++A+ I +AL++ S+ ++ D+ VL + G + FG+
Sbjct: 129 KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLV 188
Query: 225 DGKSYSTNLAYTPPEYLRNGRVTPE---------SVIFSFGTVLLDLLSGKHIPPSHALD 275
D + + P Y R+ PE S I+S G ++L + S
Sbjct: 189 DDVAKDIDAGCKP--YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP 246
Query: 276 MIRGKNILHLMDSHLEGN-FSSEEATVVFDLASRCLQYEPRERPNTKDL 323
+ K ++ L + FS+E D S+CL+ +ERP +L
Sbjct: 247 FQQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPEL 291
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 35.8 bits (81), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 43/188 (22%), Positives = 73/188 (38%), Gaps = 19/188 (10%)
Query: 97 NRRWIAVKKFTKHAWPDPK---QFADEAWGVGKLRHKRLANLI----GYCCDGDERLLVA 149
+ R +AVK DP +F EA L H + + G +V
Sbjct: 36 DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
EY+ TL + + H E + + V +AL++ G ++ D+ ++
Sbjct: 96 EYVDGVTL-RDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGI-IHRDVKPANIMISAT 152
Query: 210 GDPRLSCFGLMKNSRDGKSYSTNLA-------YTPPEYLRNGRVTPESVIFSFGTVLLDL 262
++ FG+ + D + T A Y PE R V S ++S G VL ++
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 263 LSGKHIPP 270
L+G+ PP
Sbjct: 213 LTGE--PP 218
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 35.8 bits (81), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 43/188 (22%), Positives = 73/188 (38%), Gaps = 19/188 (10%)
Query: 97 NRRWIAVKKFTKHAWPDPK---QFADEAWGVGKLRHKRLANLI----GYCCDGDERLLVA 149
+ R +AVK DP +F EA L H + + G +V
Sbjct: 36 DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
EY+ TL + + H E + + V +AL++ G ++ D+ ++
Sbjct: 96 EYVDGVTL-RDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGI-IHRDVKPANIMISAT 152
Query: 210 GDPRLSCFGLMKNSRDGKSYSTNLA-------YTPPEYLRNGRVTPESVIFSFGTVLLDL 262
++ FG+ + D + T A Y PE R V S ++S G VL ++
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 263 LSGKHIPP 270
L+G+ PP
Sbjct: 213 LTGE--PP 218
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 35.4 bits (80), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 99 RWIAVKKFTKHAWPDPK---QFADEAWGVGKLRHKRLANLIGY----CCDGDERLLVAEY 151
R +AVK DP +F EA L H + + G +V EY
Sbjct: 38 RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEY 97
Query: 152 MPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGD 211
+ TL + + H E + + V +AL++ G ++ D+ ++
Sbjct: 98 VDGVTL-RDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGI-IHRDVKPANIMISATNA 154
Query: 212 PRLSCFGLMKNSRDGKSYSTNLA-------YTPPEYLRNGRVTPESVIFSFGTVLLDLLS 264
++ FG+ + D + T A Y PE R V S ++S G VL ++L+
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 265 GKHIPP 270
G+ PP
Sbjct: 215 GE--PP 218
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 35.4 bits (80), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 13/131 (9%)
Query: 143 DERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYHDL 199
D V EY+ L H+ Q + Y AE L + S+G +Y DL
Sbjct: 415 DRLYFVMEYVNGGDLMYHI-----QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI-IYRDL 468
Query: 200 NAYRVLFDENGDPRLSCFGLMK-NSRDG---KSYSTNLAYTPPEYLRNGRVTPESVIFSF 255
V+ D G +++ FG+ K N DG K + Y PE + ++F
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 528
Query: 256 GTVLLDLLSGK 266
G +L ++L+G+
Sbjct: 529 GVLLYEMLAGQ 539
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 35.4 bits (80), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 99 RWIAVKKFTKHAWPDPK---QFADEAWGVGKLRHKRLANLI----GYCCDGDERLLVAEY 151
R +AVK DP +F EA L H + + G +V EY
Sbjct: 38 RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 152 MPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGD 211
+ TL + + H E + + V +AL++ G ++ D+ ++
Sbjct: 98 VDGVTL-RDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGI-IHRDVKPANIMISATNA 154
Query: 212 PRLSCFGLMKNSRDGKSYSTNLA-------YTPPEYLRNGRVTPESVIFSFGTVLLDLLS 264
++ FG+ + D + T A Y PE R V S ++S G VL ++L+
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 265 GKHIPP 270
G+ PP
Sbjct: 215 GE--PP 218
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 35.4 bits (80), Expect = 0.082, Method: Compositional matrix adjust.
Identities = 35/160 (21%), Positives = 66/160 (41%), Gaps = 12/160 (7%)
Query: 178 ALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN----- 232
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 206 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 233 -LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMDSHL 290
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 324
Query: 291 EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 325 PDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 360
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 35.0 bits (79), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 19/188 (10%)
Query: 97 NRRWIAVKKFTKHAWPDPK---QFADEAWGVGKLRHKRLANLI----GYCCDGDERLLVA 149
+ R +AVK DP +F EA L H + + G +V
Sbjct: 36 DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
EY+ TL + + H E + + V +AL++ G ++ D+ +L
Sbjct: 96 EYVDGVTL-RDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGI-IHRDVKPANILISAT 152
Query: 210 GDPRLSCFGLMKNSRD-GKSYSTNLA------YTPPEYLRNGRVTPESVIFSFGTVLLDL 262
++ FG+ + D G S A Y PE R V S ++S G VL ++
Sbjct: 153 NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 263 LSGKHIPP 270
L+G+ PP
Sbjct: 213 LTGE--PP 218
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 35.0 bits (79), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 99 RWIAVKKFTKHAWPDPK---QFADEAWGVGKLRHKRLANLI----GYCCDGDERLLVAEY 151
R +AVK DP +F EA L H + + G +V EY
Sbjct: 55 RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 114
Query: 152 MPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGD 211
+ TL + + H E + + V +AL++ G ++ D+ ++
Sbjct: 115 VDGVTL-RDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGI-IHRDVKPANIMISATNA 171
Query: 212 PRLSCFGLMKNSRDGKSYSTNLA-------YTPPEYLRNGRVTPESVIFSFGTVLLDLLS 264
++ FG+ + D + T A Y PE R V S ++S G VL ++L+
Sbjct: 172 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231
Query: 265 GKHIPP 270
G+ PP
Sbjct: 232 GE--PP 235
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 35.0 bits (79), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 35/160 (21%), Positives = 66/160 (41%), Gaps = 12/160 (7%)
Query: 178 ALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN----- 232
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 204 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 233 -LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMDSHL 290
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 322
Query: 291 EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 323 PDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 358
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 35.0 bits (79), Expect = 0.096, Method: Compositional matrix adjust.
Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 21/142 (14%)
Query: 138 YCCDGDERLL--VAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEG 192
+C D++ L V EYMP L + +++ +WA Y AE ALD S G
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWA-----KFYTAEVVLALDAIHSMG 194
Query: 193 RPLYHDLNAYRVLFDENGDPRLSCFGL-MKNSRDGKSYSTNLAYTP----PEYLR----N 243
++ D+ +L D++G +L+ FG MK G + TP PE L+ +
Sbjct: 195 L-IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 244 GRVTPESVIFSFGTVLLDLLSG 265
G E +S G L ++L G
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVG 275
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 35.0 bits (79), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 8/154 (5%)
Query: 114 PKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAM 173
P E + +L+HK + L + LV E+ D K F N ++ +
Sbjct: 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEI 102
Query: 174 RLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKN----SRDGKSY 229
+ + L +C S L+ DL +L + NG+ +L+ FGL + R +
Sbjct: 103 VKSFLFQLLKGLGFCHSRNV-LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161
Query: 230 STNLAYTPPEYLRNGRVTPESV-IFSFGTVLLDL 262
L Y PP+ L ++ S+ ++S G + +L
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 35.0 bits (79), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 35/160 (21%), Positives = 66/160 (41%), Gaps = 12/160 (7%)
Query: 178 ALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN----- 232
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 199 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 233 -LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMDSHL 290
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317
Query: 291 EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 318 PDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 353
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 35.0 bits (79), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 25/73 (34%), Positives = 36/73 (49%), Gaps = 2/73 (2%)
Query: 150 EYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDEN 209
EY N TL L H EN + R+ I EAL Y S+G ++ +L + DE+
Sbjct: 95 EYCENRTLYD-LIHSENLNQQRDEYWRLFRQILEALSYIHSQG-IIHRNLKPXNIFIDES 152
Query: 210 GDPRLSCFGLMKN 222
+ ++ FGL KN
Sbjct: 153 RNVKIGDFGLAKN 165
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 35.0 bits (79), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 35/160 (21%), Positives = 66/160 (41%), Gaps = 12/160 (7%)
Query: 178 ALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN----- 232
+ +A+ +++ +S + ++ DL A +L E ++ FGL ++ Y
Sbjct: 197 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 233 -LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGKHIP-PSHALDMIRGKNILHLMDSHL 290
L + PE + + T +S ++SFG +L ++ S P P +D + +
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 315
Query: 291 EGNFSSEEATVVFDLASRCLQYEPRERPNTKDLVSTLAPL 330
+ E + D C EP +RP +LV L L
Sbjct: 316 PDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 351
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 28/166 (16%)
Query: 176 RVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSYSTN--- 232
++ + I +AL Y + ++ D+ +L DE G +L FG+ D K+ +
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 233 LAYTPPEYLRNGRVTP----------ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNI 282
AY PE R+ P + ++S G L++L +G+ + D +
Sbjct: 188 AAYMAPE-----RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 283 LH----LMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
L L+ H+ FS + + V D CL + R+RP L+
Sbjct: 243 LQEEPPLLPGHM--GFSGDFQSFVKD----CLTKDHRKRPKYNKLL 282
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 12/135 (8%)
Query: 139 CCDGDERLL-VAEYMPNDTLAKHLFHWENQTI--EWAMRLRVALYIAEALDYCSSEGRPL 195
C + RL V EY+ L +FH + Q E R A I+ AL+Y G +
Sbjct: 89 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG-II 143
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMKNS-RDGKSYSTNLA---YTPPEYLRNGRVTPESV 251
Y DL VL D G +L+ +G+ K R G + S Y PE LR
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVD 203
Query: 252 IFSFGTVLLDLLSGK 266
++ G ++ ++++G+
Sbjct: 204 WWALGVLMFEMMAGR 218
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 35.0 bits (79), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 13/131 (9%)
Query: 143 DERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYHDL 199
D V EY+ L H+ Q + Y AE L + S+G +Y DL
Sbjct: 94 DRLYFVMEYVNGGDLMYHI-----QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI-IYRDL 147
Query: 200 NAYRVLFDENGDPRLSCFGLMK-NSRDG---KSYSTNLAYTPPEYLRNGRVTPESVIFSF 255
V+ D G +++ FG+ K N DG K + Y PE + ++F
Sbjct: 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 256 GTVLLDLLSGK 266
G +L ++L+G+
Sbjct: 208 GVLLYEMLAGQ 218
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 34.7 bits (78), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 66 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 121
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K++ Y PE L
Sbjct: 122 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 180
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGR 205
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 34.7 bits (78), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 139 CCDGDERLL-VAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
C + RL V EY+ L H+ + + E R A I+ AL+Y G +Y
Sbjct: 78 CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSA-EISLALNYLHERG-IIYR 134
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNS-RDGKSYSTNLA---YTPPEYLRNGRVTPESVIF 253
DL VL D G +L+ +G+ K R G + S Y PE LR +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWW 194
Query: 254 SFGTVLLDLLSGK 266
+ G ++ ++++G+
Sbjct: 195 ALGVLMFEMMAGR 207
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 139 CCDGDERLL-VAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSSEGRPLYH 197
C + RL V EY+ L H+ + + E R A I+ AL+Y G +Y
Sbjct: 74 CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSA-EISLALNYLHERG-IIYR 130
Query: 198 DLNAYRVLFDENGDPRLSCFGLMKNS-RDGKSYSTNLA---YTPPEYLRNGRVTPESVIF 253
DL VL D G +L+ +G+ K R G + S Y PE LR +
Sbjct: 131 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWW 190
Query: 254 SFGTVLLDLLSGK 266
+ G ++ ++++G+
Sbjct: 191 ALGVLMFEMMAGR 203
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 34.7 bits (78), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 63 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K++ Y PE L
Sbjct: 119 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 34.7 bits (78), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 63 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K++ Y PE L
Sbjct: 119 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 34.7 bits (78), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 17/110 (15%)
Query: 170 EWAMRLRVALYIAEALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNSRDGKSY 229
E ++ L + L IAEA+++ S+G ++ DL + F + ++ FGL+ +
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGL-MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 230 STNLAYTPPEYLRNGRV------TPESV----------IFSFGTVLLDLL 263
T L P G+V +PE + IFS G +L +LL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 57/281 (20%), Positives = 110/281 (39%), Gaps = 45/281 (16%)
Query: 101 IAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGYCCDGDERLLVAEYMPNDTLAKH 160
+A+K+ + + K F E + ++ H + L G C + LV EY +L
Sbjct: 35 VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 90
Query: 161 L-------FHWENQTIEWAMRLRVALYIAEALDYCSS-EGRPLYH-DLNAYRVLFDENGD 211
L ++ + W ++ ++ + Y S + + L H DL +L G
Sbjct: 91 LHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 144
Query: 212 PRLSC-FGLMKNSRDGKSYSTN----LAYTPPEYLRNGRVTPESVIFSFGTVLLDLLSGK 266
C FG + D +++ TN A+ PE + + +FS+G +L ++++ +
Sbjct: 145 VLKICDFG---TACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 201
Query: 267 HIPPSHALDMIRGK--NILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRERPNTKDLV 324
D I G I+ + + + L +RC +P +RP+ +++V
Sbjct: 202 K-----PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 256
Query: 325 STLAPLQNRPDVPSYVMLGIPRHEEAPPTP-QHPLSPMGDA 364
+ +++M P +E P QH L P D
Sbjct: 257 KIM----------THLMRYFPGADEPLQYPCQHSLPPGEDG 287
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 141 DGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSS--EGRPLYHD 198
D + LV +Y L L +E++ E R YI E + S + ++ D
Sbjct: 145 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF----YIGEMVLAIDSIHQLHYVHRD 200
Query: 199 LNAYRVLFDENGDPRLSCFG-LMKNSRDGKSYSTNLAYTP----PEYLRN-----GRVTP 248
+ VL D NG RL+ FG +K + DG S+ TP PE L+ G+ P
Sbjct: 201 IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 260
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILH 284
E +S G + ++L G+ + +L GK + H
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 40/137 (29%), Positives = 58/137 (42%), Gaps = 21/137 (15%)
Query: 195 LYHDLNAYRVLFDENGDPRLSCFGLMKNSRDG---KSYSTNLAYTPPEYLR------NGR 245
++ DL +L D+N RLS FG + G + Y PE L+ +
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
Query: 246 VTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILHL-MDSHLEGNFSSEE----AT 300
E +++ G +L LL+G PP + IL L M + FSS E ++
Sbjct: 282 YGKEVDLWACGVILFTLLAGS--PP-----FWHRRQILMLRMIMEGQYQFSSPEWDDRSS 334
Query: 301 VVFDLASRCLQYEPRER 317
V DL SR LQ +P R
Sbjct: 335 TVKDLISRLLQVDPEAR 351
>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
pdb|3JUH|B Chain B, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
Length = 335
Score = 34.3 bits (77), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + VL D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 50/303 (16%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFADEAWGVGKLRHKRLANLIGY 138
G A VV K + + + +A+K+ + + K F E + ++ H + L G
Sbjct: 17 GRGAFGVVCKAKWRAKD-----VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 139 CCDGDERLLVAEYMPNDTLAKHL-------FHWENQTIEWAMRLRVALYIAEALDYCSS- 190
C + LV EY +L L ++ + W ++ ++ + Y S
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSM 121
Query: 191 EGRPLYH-DLNAYRVLFDENGDPRLSC-FGLMKNSRDGKSYSTN----LAYTPPEYLRNG 244
+ + L H DL +L G C FG + D +++ TN A+ PE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 245 RVTPESVIFSFGTVLLDLLSGKHIPPSHALDMIRGK--NILHLMDSHLEGNFSSEEATVV 302
+ + +FS+G +L ++++ + D I G I+ + + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRK-----PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 303 FDLASRCLQYEPRERPNTKDLVSTLAPLQNRPDVPSYVMLGIPRHEEAPPTP-QHPLSPM 361
L +RC +P +RP+ +++V + +++M P +E P QH L P
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIM----------THLMRYFPGADEPLQYPCQHSLPPG 283
Query: 362 GDA 364
D
Sbjct: 284 EDG 286
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 141 DGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAEALDYCSS--EGRPLYHD 198
D + LV +Y L L +E++ E R YI E + S + ++ D
Sbjct: 161 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF----YIGEMVLAIDSIHQLHYVHRD 216
Query: 199 LNAYRVLFDENGDPRLSCFG-LMKNSRDGKSYSTNLAYTP----PEYLRN-----GRVTP 248
+ VL D NG RL+ FG +K + DG S+ TP PE L+ G+ P
Sbjct: 217 IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 276
Query: 249 ESVIFSFGTVLLDLLSGKHIPPSHALDMIRGKNILH 284
E +S G + ++L G+ + +L GK + H
Sbjct: 277 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 312
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 33.9 bits (76), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 68 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 123
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K + Y PE L
Sbjct: 124 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 182
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGR 207
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 33.9 bits (76), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 63 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K + Y PE L
Sbjct: 119 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 33.9 bits (76), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 63 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K + Y PE L
Sbjct: 119 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 33.9 bits (76), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 128 RHKRLANLIGYCCDGDERL-LVAEYMPNDTLAKHLFHWENQTIEWAMRLRV-ALYIAEAL 185
RH L L Y +RL V EY L FH + + R R I AL
Sbjct: 63 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 186 DYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGLMKNS-RDG---KSYSTNLAYTPPEYL 241
+Y S +Y D+ ++ D++G +++ FGL K DG K + Y PE L
Sbjct: 119 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 242 RNGRVTPESVIFSFGTVLLDLLSGK 266
+ + G V+ +++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme
pdb|4DGL|D Chain D, Crystal Structure Of The Ck2 Tetrameric Holoenzyme
Length = 335
Score = 33.5 bits (75), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
pdb|3H30|B Chain B, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
Length = 334
Score = 33.5 bits (75), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 33.5 bits (75), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|B Chain B, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|C Chain C, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|D Chain D, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
Length = 335
Score = 33.5 bits (75), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3NGA|B Chain B, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3U4U|A Chain A, Casein Kinase 2 In Complex With Az-Inhibitor
Length = 333
Score = 33.5 bits (75), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Cpa)
pdb|3MB7|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Amr)
pdb|3OWJ|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Pyridocarbazole Derivative Inhibitor
pdb|3OWK|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
pdb|3OWL|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
Length = 331
Score = 33.5 bits (75), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3C13|A Chain A, Low Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3FWQ|A Chain A, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3FWQ|B Chain B, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3RPS|A Chain A, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3RPS|B Chain B, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3U9C|A Chain A, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|3U9C|B Chain B, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|4FBX|A Chain A, Complex Structure Of Human Protein Kinase Ck2 Catalytic
Subunit Crystallized In The Presence Of A Bisubstrate
Inhibitor
Length = 335
Score = 33.5 bits (75), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 8.5
pdb|3Q9X|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9X|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9Y|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 8.5
pdb|3Q9Z|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3Q9Z|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3QA0|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
pdb|3QA0|B Chain B, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
Length = 336
Score = 33.5 bits (75), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|1JWH|B Chain B, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|3PE1|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-4945
pdb|3PE2|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 In Complex
With The Inhibitor Cx-5011
pdb|3R0T|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-5279
Length = 337
Score = 33.5 bits (75), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
pdb|3U87|B Chain B, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
Length = 349
Score = 33.5 bits (75), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 133 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn
Length = 330
Score = 33.5 bits (75), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 132 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human
Protein Kinase Ck2 Catalytic Subunit
pdb|2PVR|A Chain A, Crystal Structure Of The Catalytic Subunit Of Protein
Kinase Ck2 (c- Terminal Deletion Mutant 1-335) In
Complex With Two Sulfate Ions
Length = 334
Score = 33.5 bits (75), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 132 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
8.5
Length = 328
Score = 33.1 bits (74), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 131 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 189
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Ellagic Acid
pdb|3AMY|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Apigenin
pdb|3AT2|A Chain A, Crystal Structure Of Ck2alpha
pdb|3AT3|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivative
pdb|3AT4|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivertive
pdb|3AXW|A Chain A, Crystal Structure Of Human Ck2alpha Complexed With A
Potent Inhibitor
Length = 340
Score = 33.1 bits (74), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y I +ALDYC S G ++ D+ + V+ D E+ RL +GL + G+ Y+
Sbjct: 138 IRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 196
Query: 233 LA---YTPPEYLRNGRVTPESV-IFSFGTVLLDLLSGK 266
+A + PE L + ++ S+ ++S G +L ++ K
Sbjct: 197 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 234
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 33.1 bits (74), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 13/106 (12%)
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL-MKNSRDGKSYSTNLAYTP---- 237
+AL+Y + + ++ DL A +LF +GD +L+ FG+ KN+R + TP
Sbjct: 119 DALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPYWMA 177
Query: 238 PEYL--RNGRVTP---ESVIFSFGTVLLDLLSGKHIPPSHALDMIR 278
PE + + P ++ ++S G L+++ + PP H L+ +R
Sbjct: 178 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMR 221
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 32.7 bits (73), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 18/196 (9%)
Query: 79 GEKAPNVVYKGRLQDGNDNRRWIAVKKFTKHAWPDPKQFAD-----EAWGVGKLRHKRLA 133
GE VYK R D N N+ +A+KK + K + E + +L H +
Sbjct: 19 GEGQFATVYKAR--DKNTNQ-IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 134 NLIGYCCDGDERLLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIA-EALDYCSSEG 192
L+ LV ++M D + +N + ++ + + + L+Y
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 193 RPLYHDLNAYRVLFDENGDPRLSCFGLMKN-SRDGKSYSTNLA---YTPPEYLRNGRVTP 248
L+ DL +L DENG +L+ FGL K+ ++Y + Y PE L R+
Sbjct: 133 I-LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 249 ESV-IFSFGTVLLDLL 263
V +++ G +L +LL
Sbjct: 192 VGVDMWAVGCILAELL 207
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 32.3 bits (72), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 55/105 (52%), Gaps = 12/105 (11%)
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL-MKNSRDGK---SYSTNLAYTPP 238
+AL+Y + + ++ DL A +LF +GD +L+ FG+ KN+R + S+ + P
Sbjct: 146 DALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 239 EYL--RNGRVTP---ESVIFSFGTVLLDLLSGKHIPPSHALDMIR 278
E + + P ++ ++S G L+++ + PP H L+ +R
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMR 247
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 32.3 bits (72), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 55/105 (52%), Gaps = 12/105 (11%)
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL-MKNSRDGK---SYSTNLAYTPP 238
+AL+Y + + ++ DL A +LF +GD +L+ FG+ KN+R + S+ + P
Sbjct: 146 DALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 239 EYL--RNGRVTP---ESVIFSFGTVLLDLLSGKHIPPSHALDMIR 278
E + + P ++ ++S G L+++ + PP H L+ +R
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMR 247
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 32.3 bits (72), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 143 DERLL--VAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYH 197
D+R L V EYMP L + +++ +WA Y AE ALD S G ++
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWA-----RFYTAEVVLALDAIHSMGF-IHR 192
Query: 198 DLNAYRVLFDENGDPRLSCFGL-MKNSRDGKSYSTNLAYTP----PEYLR----NGRVTP 248
D+ +L D++G +L+ FG MK +++G TP PE L+ +G
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252
Query: 249 ESVIFSFGTVLLDLLSG 265
E +S G L ++L G
Sbjct: 253 ECDWWSVGVFLYEMLVG 269
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 32.3 bits (72), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 143 DERLL--VAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYH 197
D+R L V EYMP L + +++ +WA Y AE ALD S G ++
Sbjct: 145 DDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWA-----RFYTAEVVLALDAIHSMGF-IHR 197
Query: 198 DLNAYRVLFDENGDPRLSCFGL-MKNSRDGKSYSTNLAYTP----PEYLR----NGRVTP 248
D+ +L D++G +L+ FG MK +++G TP PE L+ +G
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 257
Query: 249 ESVIFSFGTVLLDLLSG 265
E +S G L ++L G
Sbjct: 258 ECDWWSVGVFLYEMLVG 274
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 32.0 bits (71), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 143 DERLL--VAEYMPNDTLAKHLFHWENQTIEWAMRLRVALYIAE---ALDYCSSEGRPLYH 197
D+R L V EYMP L + +++ +WA Y AE ALD S G ++
Sbjct: 145 DDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWA-----RFYTAEVVLALDAIHSMGF-IHR 197
Query: 198 DLNAYRVLFDENGDPRLSCFGL-MKNSRDGKSYSTNLAYTP----PEYLR----NGRVTP 248
D+ +L D++G +L+ FG MK +++G TP PE L+ +G
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 257
Query: 249 ESVIFSFGTVLLDLLSG 265
E +S G L ++L G
Sbjct: 258 ECDWWSVGVFLYEMLVG 274
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 32.0 bits (71), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 23/161 (14%)
Query: 143 DERLLVAEYMPNDTLAKHLFHW----ENQTIEWAMRLRVALYIAEALDYCSSEGRPLYHD 198
D V EY+ L H+ E Q + +A + + L+ + G +Y D
Sbjct: 93 DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF------FLHKRGI-IYRD 145
Query: 199 LNAYRVLFDENGDPRLSCFGLMK-NSRDG---KSYSTNLAYTPPEYLRNGRVTPESVIFS 254
L V+ D G +++ FG+ K + DG + + Y PE + ++
Sbjct: 146 LKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWA 205
Query: 255 FGTVLLDLLSGKHIPPSHALDMIRGKNILHLMDSHLEGNFS 295
+G +L ++L+G+ PP G++ L S +E N S
Sbjct: 206 YGVLLYEMLAGQ--PP------FDGEDEDELFQSIMEHNVS 238
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 10/128 (7%)
Query: 146 LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALY-IAEALDYCSSEGRPLYHDLNAYRV 204
LL EY L K+L +EN +R L I+ AL Y E R ++ DL +
Sbjct: 95 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENI 153
Query: 205 LFDENGDPRLSC----FGLMKNSRDGK---SYSTNLAYTPPEYLRNGRVTPESVIFSFGT 257
+ + G RL G K G+ + L Y PE L + T +SFGT
Sbjct: 154 VL-QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 212
Query: 258 VLLDLLSG 265
+ + ++G
Sbjct: 213 LAFECITG 220
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 10/128 (7%)
Query: 146 LLVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALY-IAEALDYCSSEGRPLYHDLNAYRV 204
LL EY L K+L +EN +R L I+ AL Y E R ++ DL +
Sbjct: 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENI 152
Query: 205 LFDENGDPRLSC----FGLMKNSRDGK---SYSTNLAYTPPEYLRNGRVTPESVIFSFGT 257
+ + G RL G K G+ + L Y PE L + T +SFGT
Sbjct: 153 VL-QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 258 VLLDLLSG 265
+ + ++G
Sbjct: 212 LAFECITG 219
>pdb|3FP2|A Chain A, Crystal Structure Of Tom71 Complexed With Hsp82 C-Terminal
Fragment
pdb|3FP3|A Chain A, Crystal Structure Of Tom71
pdb|3FP4|A Chain A, Crystal Structure Of Tom71 Complexed With Ssa1 C-Terminal
Fragment
Length = 537
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 1/95 (1%)
Query: 397 TQQMRDMLEARKRGDVAFREKEFKTAVDCYSQFIDVGTMVSPTVYARRSLCHLMCDQPDA 456
+Q+ ++ + RG+ F K F A+ Y I++ P Y+ S C++ +
Sbjct: 19 SQRQAYAVQLKNRGNHFFTAKNFNEAIKYYQYAIELDPN-EPVFYSNISACYISTGDLEK 77
Query: 457 ALRDAMQAQCVYPDWSTAFYMQAVALAKLDMHKDA 491
+ +A + PD S A +A A L DA
Sbjct: 78 VIEFTTKALEIKPDHSKALLRRASANESLGNFTDA 112
>pdb|3LCA|A Chain A, Structure Of Tom71 Complexed With Hsp70 Ssa1 C Terminal
Tail Indicating Conformational Plasticity
Length = 533
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 1/95 (1%)
Query: 397 TQQMRDMLEARKRGDVAFREKEFKTAVDCYSQFIDVGTMVSPTVYARRSLCHLMCDQPDA 456
+Q+ ++ + RG+ F K F A+ Y I++ P Y+ S C++ +
Sbjct: 15 SQRQAYAVQLKNRGNHFFTAKNFNEAIKYYQYAIELDPN-EPVFYSNISACYISTGDLEK 73
Query: 457 ALRDAMQAQCVYPDWSTAFYMQAVALAKLDMHKDA 491
+ +A + PD S A +A A L DA
Sbjct: 74 VIEFTTKALEIKPDHSKALLRRASANESLGNFTDA 108
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 34/123 (27%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 147 LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALY-IAEALDYCSSEGRPLYHDLNAYRVL 205
LV EY+ N+T K L+ I +R +Y + +ALDYC S+G ++ D+ + V+
Sbjct: 117 LVFEYI-NNTDFKQLYQ-----ILTDFDIRFYMYELLKALDYCHSKG-IMHRDVKPHNVM 169
Query: 206 FD-ENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRNGRVTPESV-IFSFGTVLL 260
D + RL +GL + + Y+ +A + PE L + ++ S+ ++S G +L
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 261 DLL 263
++
Sbjct: 230 SMI 232
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 34/123 (27%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 147 LVAEYMPNDTLAKHLFHWENQTIEWAMRLRVALY-IAEALDYCSSEGRPLYHDLNAYRVL 205
LV EY+ N+T K L+ I +R +Y + +ALDYC S+G ++ D+ + V+
Sbjct: 112 LVFEYI-NNTDFKQLYQ-----ILTDFDIRFYMYELLKALDYCHSKG-IMHRDVKPHNVM 164
Query: 206 FD-ENGDPRLSCFGLMKNSRDGKSYSTNLA---YTPPEYLRNGRVTPESV-IFSFGTVLL 260
D + RL +GL + + Y+ +A + PE L + ++ S+ ++S G +L
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 261 DLL 263
++
Sbjct: 225 SMI 227
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 27/105 (25%), Positives = 54/105 (51%), Gaps = 12/105 (11%)
Query: 183 EALDYCSSEGRPLYHDLNAYRVLFDENGDPRLSCFGL-MKNSRDGKSYSTNLA---YTPP 238
+AL+Y + + ++ DL A +LF +GD +L+ FG+ KN+R + + + P
Sbjct: 146 DALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 239 EYL--RNGRVTP---ESVIFSFGTVLLDLLSGKHIPPSHALDMIR 278
E + + P ++ ++S G L+++ + PP H L+ +R
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMR 247
>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc
pdb|3FL5|A Chain A, Protein Kinase Ck2 In Complex With The Inhibitor
Quinalizarin
pdb|3PZH|A Chain A, Crystal Structure Of Maize Ck2 Alpha In Complex With
Emodin At 1.92 A Resolution
Length = 332
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 128 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 187 VASRYFKGPELL 198
>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex
With The Inhibitor
4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68)
Length = 331
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 127 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 186 VASRYFKGPELL 197
>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVJ|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVK|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVL|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVM|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVN|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|3BE9|A Chain A, Structure-Based Design And Synthesis Of Novel Macrocyclic
Pyrazolo[1,5-A] [1,3,5]triazine Compounds As Potent
Inhibitors Of Protein Kinase Ck2 And Their Anticancer
Activities
Length = 352
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 148 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 207 VASRYFKGPELL 218
>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1DS5|B Chain B, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1DS5|C Chain C, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1DS5|D Chain D, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1F0Q|A Chain A, Crystal Structure Of The Alpha Subunit Of Protein Kinase
Ck2 In Complex With The Nucleotide Competitive Inhibitor
Emodin
pdb|1J91|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Atp-Competitive Inhibitor 4,5,6,7-
Tetrabromobenzotriazole
pdb|1J91|B Chain B, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Atp-Competitive Inhibitor 4,5,6,7-
Tetrabromobenzotriazole
pdb|1JAM|A Chain A, Crystal Structure Of Apo-Form Of Z. Mays Ck2 Protein
Kinase Alpha Subunit
pdb|1LP4|A Chain A, Crystal Structure Of A Binary Complex Of The Catalytic
Subunit Of Protein Kinase Ck2 With Mg-Amppnp
pdb|1LPU|A Chain A, Low Temperature Crystal Structure Of The Apo-Form Of The
Catalytic Subunit Of Protein Kinase Ck2 From Zea Mays
pdb|1LR4|A Chain A, Room Temperature Crystal Structure Of The Apo-Form Of The
Catalytic Subunit Of Protein Kinase Ck2 From Zea Mays
pdb|1OM1|A Chain A, Crystal Structure Of Maize Ck2 Alpha In Complex With Iqa
pdb|1ZOE|A Chain A, Crystal Structure Of Protein Kinase Ck2 In Complex With
Tbb- Derivatives Inhibitors
pdb|1ZOG|A Chain A, Crystal Structure Of Protein Kinase Ck2 In Complex With
Tbb- Derivatives
pdb|1ZOH|A Chain A, Crystal Structure Of Protein Kinase Ck2 In Complex With
Tbb- Derivatives Inhibitors
pdb|2OXD|A Chain A, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole K17, K22 And K32 Inhibitors
pdb|2OXX|A Chain A, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole Derivatives K17, K22 And K32
pdb|2OXY|A Chain A, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole Derivatives K17, K22 And K32
pdb|2OXY|B Chain B, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole Derivatives K17, K22 And K32
pdb|3PWD|A Chain A, Crystal Structure Of Maize Ck2 In Complex With Nbc (Z1)
Length = 332
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 128 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 187 VASRYFKGPELL 198
>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The
Inhibitor Luteolin
Length = 326
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 127 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 186 VASRYFKGPELL 197
>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The
Inhibitor Apigenin
Length = 326
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 127 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 186 VASRYFKGPELL 197
>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor
3,4,5,6,7-Pentabromo-1h-Indazole (K64)
pdb|3KXH|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor
(2-Dymethylammino-4,5,6,7-Tetrabromobenzoimidazol-1yl-
Acetic Acid (K66)
Length = 327
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 127 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 186 VASRYFKGPELL 197
>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor
Length = 335
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 129 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 188 VASRYFKGPELL 199
>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro-
AnthraquinoneCK2 KINASE COMPLEX
pdb|4DGO|A Chain A, Crystal Structure Of Maize Ck2 In Complex With Tyrphostin
Ag99
Length = 325
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 127 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 186 VASRYFKGPELL 197
>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase
Ck2 (Alpha-Subunit) And Mg-Amppnp
pdb|1DAY|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase
Ck2 (Alpha-Subunit) And Mg-Gmppnp
pdb|1M2Q|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro-Xanten-9-
OneCK2 KINASE COMPLEX
pdb|1M2R|A Chain A, Crystal Structure Of 5,8-Di-Amino-1,4-Di-Hydroxy-
AnthraquinoneCK2 KINASE COMPLEX
pdb|3KXM|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor K74
pdb|3KXN|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor Tetraiodobenzimidazole (K88)
Length = 327
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 175 LRVALY-IAEALDYCSSEGRPLYHDLNAYRVLFD-ENGDPRLSCFGLMKNSRDGKSYSTN 232
+R +Y + +ALDYC S+G ++ D+ + V+ D E RL +GL + GK Y+
Sbjct: 127 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 233 LA---YTPPEYL 241
+A + PE L
Sbjct: 186 VASRYFKGPELL 197
>pdb|2X5Q|A Chain A, Crystal Structure Of Hypothetical Protein Sso1986 From
Sulfolobus Solfataricus P2
pdb|2X5Q|B Chain B, Crystal Structure Of Hypothetical Protein Sso1986 From
Sulfolobus Solfataricus P2
Length = 198
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%)
Query: 362 GDACSRMDLTAIHQILVMTHYKDDEGTNEL 391
G S++D +H ILV+T Y DE T EL
Sbjct: 42 GQHVSQIDDKGLHNILVLTGYAIDESTGEL 71
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.4 bits (67), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 30.0 bits (66), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 186 PVDVWSCGIVLTAMLAGE 203
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 30.0 bits (66), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.0 bits (66), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 30.0 bits (66), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 30.0 bits (66), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.0 bits (66), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 196 YHDLNAYRVLFDENGDPRLSCFGLMK----NSRDG--KSYSTNLAYTPPEYLRNGRVTPE 249
+ D+ +L DE + ++S FGL N+R+ L Y PE L+ E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 SV-IFSFGTVLLDLLSGK 266
V ++S G VL +L+G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204
>pdb|2GW1|A Chain A, Crystal Structure Of The Yeast Tom70
pdb|2GW1|B Chain B, Crystal Structure Of The Yeast Tom70
Length = 514
Score = 29.3 bits (64), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 404 LEARKRGDVAFREKEFKTAVDCYSQFIDVGTMVSPTVYARRSLCHLMCDQPDAALRDAMQ 463
L + +G+ FR K++ A+ Y+ +++ P Y+ S C++ + + +
Sbjct: 7 LALKDKGNQFFRNKKYDDAIKYYNWALELKE--DPVFYSNLSACYVSVGDLKKVVEMSTK 64
Query: 464 AQCVYPDWSTAFYMQAVALAKLDMHKDA 491
A + PD+S +A A L DA
Sbjct: 65 ALELKPDYSKVLLRRASANEGLGKFADA 92
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 28.5 bits (62), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 46/198 (23%), Positives = 74/198 (37%), Gaps = 46/198 (23%)
Query: 196 YHDLNAYRVLFDE-NGDPRLSCFGLMKN---SRDGKSYSTNLAYTPPEYL-RNGRVTPES 250
+ D+ + VL +E +G +L FG K S +Y + Y PE + N T
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAV 213
Query: 251 VIFSFGTVLLDLLSG----------------------------KHIPPSHA-LDMIRGKN 281
I+S G + +++ G + + PSH +D+ K
Sbjct: 214 DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKG 273
Query: 282 ILHLMDSHLEGNFSSEEATVVFDLASRCLQYEPRER---------PNTKDLVSTLAPLQN 332
I S++ + S ++A +DL S LQY P ER P +L L N
Sbjct: 274 IPW---SNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPN 330
Query: 333 RPDVPSYVMLGIPRHEEA 350
D+P + +P E
Sbjct: 331 NKDLPEDLFRFLPNEIEV 348
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.134 0.411
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 15,184,829
Number of Sequences: 62578
Number of extensions: 638081
Number of successful extensions: 1965
Number of sequences better than 100.0: 524
Number of HSP's better than 100.0 without gapping: 80
Number of HSP's successfully gapped in prelim test: 444
Number of HSP's that attempted gapping in prelim test: 1559
Number of HSP's gapped (non-prelim): 542
length of query: 512
length of database: 14,973,337
effective HSP length: 103
effective length of query: 409
effective length of database: 8,527,803
effective search space: 3487871427
effective search space used: 3487871427
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 54 (25.4 bits)